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ABSTRACT 
 
 
Transcriptional Regulation of the Shigella flexneri promoter: 
Silencing and Anti-silencing by H-NS and VirB 
 
 
by 
 
 
Lieutenant Dustin John Harrison  
Medical Service Corps  
U.S. Navy 
 
Dr. Helen J Wing, Examination Committee Chair 
Assistant Professor of Science 
University of Nevada, Las Vegas 
 
 Shigella species are gram-negative intracellular pathogens that cause bacillary 
dysentery in humans.  Many genes required for virulence of Shigella are carried on a 
large 230 kb plasmid and many of these are under the transcriptional control of the 
histone-like nucleoid structuring protein (H-NS) and by the major virulence regulator 
VirB.  At the non-permissive temperature of 30⁰C, H-NS represses transcription, while at 
37⁰C VirB alleviates this repression. This mechanism of gene regulation has been coined 
“silencing/anti-silencing” and is commonly found in many important bacterial pathogens 
including Salmonella spp. and Yersinia spp. The icsP gene, encoded by the Shigella 
virulence plasmid, is positively controlled by VirB and negatively by H-NS.  The icsP 
gene encodes an outermembrane protease respsonsible for maintaining the tight polar cap 
of the actin polymerization protein IcsA, which is involved in the inter-, and intracellular 
spread of Shigella.   
 Our work has revealed that sequences located over 1 kb upstream of the icsP 
annotated transcription start site (+1) are needed for the VirB-dependent regulation of the 
 iv 
icsP promoter.  Using site directed mutagenesis we identified two DNA sequences that 
are required for the VirB dependent regulation of the icsP promoter, both of which 
display good matches to the reported consensus VirB binding site.  We demonstrate that 
sequences located upstream of position -665 relative to the annotated transcription start 
site are needed for complete H-NS-mediated silencing of the icsP promoter.   
 Using electrophoretic mobility shift assays (EMSAs), and DNase I footprint analysis 
we show that VirB and H-NS bind directly to DNA sequences located both upstream of -
665 and downstream of -213 by and that these regions are predicted to display high levels 
of intrinsic curvature.  While we demonstrate that VirB functions to solely de-repress the 
icsP promoter, our EMSA data indicate that VirB and H-NS are capable of binding to the 
full upstream intergenic region (1232 bp) of the icsP gene simultaneously.  These in vitro 
data suggest that VirB may function to relocate H-NS bound to the region immediately 
upstream of the icsP gene, rather than displacing H-NS from the DNA.   
 Our data also suggest that disruption of single regions of predicted curvature, 
contained within the upstream intergenic region of icsP, does not have an effect on either 
the ability of H-NS to silence the promoter or the ability of VirB to alleviate the H-NS 
induced repression. 
 Taken together our data suggest that remote regulation of the icsP promoter requires 
promoter proximal sequences that act in concert with upstream sequences. Our findings 
raise the possibility that other bacterial promoters may be regulated by DNA-binding 
proteins binding to remote DNA sequence elements.  My work improves our 
understanding of transcriptional silencing and anti-silencing, a regulatory event that 
controls the expression of many virulence genes in many important enteric pathogens. 
 v 
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“The views expressed in this article are those of the author and do not necessarily reflect 
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CHAPTER 1 
 
INTRODUCTION 
 The choreography of cellular processes is quite possibly one of the least understood, 
and most interesting, challenges facing molecular biologists.  These processes, e.g. 
transcription, translation, replication, trafficking, and the myriad of mechanisms that 
control and regulate them are central to understanding life, not only in eukaryotes but 
prokaryotes as well.  The regulation of just one of these processes, transcription, contains 
multiple pathways designed to effectively control gene expression by down-regulating 
the amount of gene products produced.  At any one time, an organism only expresses a 
fraction of its total potential, the rest is “turned off” (Yarmolinsky, 2000).  There are two 
ways in which a gene may be “turned off.”  One way is repression, which is defined as 
the binding of a protein at a promoter specific binding-site, which interferes locally with 
RNA polymerase (RNAP) function (Yarmolinsky, 2000).  The other way is by a process 
termed transcriptional silencing, which can be defined as a process that renders 
appreciable regions of DNA inaccessible to proteins such as RNA polymerase, DNA 
modifying enzymes, etc., to which it would otherwise be able (Dorman et al, 1999, 
Yarmolinsky, 2000).  However, the distinction between repression and silencing seems 
arbitrary and it is often difficult to distinguish the two, e.g. a silencing protein can 
interfere with RNAP function but perhaps the specific binding site is not yet known. 
Transcriptional regulation is a critical process that allows prokaryotic cells to quickly 
adapt to constantly changing environmental conditions, nutrient concentrations, stress, 
and antibiotics in order to exploite its desired niche.   
 
 2 
1.1 Transcriptional silencing 
 
 Gram-negative bacteria, like E. coli, contain at least 12 distinct types of nucleoid-
associated proteins, each with its own expression pattern and DNA-binding differences 
(Ali Azam et al, 1999, Dorman, 2004).  These nucleoid-associated proteins (NAPs) are 
direct DNA binding proteins that often have global influences on transcriptional 
expression.  Many NAPs are involved in down-regulating transcription while others are 
involved in up-regulating transcription, and still others have the ability to do both.  They 
are often referred to as histone-like, however, this is based on the functional similarity to 
eukaryotic histones and is not based on sequence or amino-acid similarity (Dorman, 
2004).  Like eukaryotic histones, many of these proteins have been shown to condense 
DNA in vitro and in vivo.  Although many types of NAPs exist the most extensively 
studied is the histone-like nucleoid structuring protein, H-NS, its paralogue StpA, the 
factor for inversion stimulation (Fis), the heat-unstable protein (HU), and the integration 
host factor protein (IHF). My research has focused mainly on H-NS and its regulation of 
the Shigella flexneri gene icsP. 
The histone-like nucleoid structuring protein 
 H-NS is a small, 15 kDa, chromosomally encoded, protein with an intracellular 
concentration of ~20 µM (Ali Azam et al., 1999, Bouffartigues et al, 2007, Spassky et al, 
1984).  The protein is expressed at a relatively constant level throughout the growth cycle 
(Dersch et al, 1993).  H-NS functions as a global repressor of gene transcription and is 
responsible for the organization and higher-order structure of the bacterial chromosome 
(Ali Azam et al., 1999, Dorman, 2004).   The concept of transcriptional silencing by H-
NS arises from the observations that certain operons in E. coli and Salmonella are under 
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the negative control of this protein, with the important H-NS binding regions being 
located outside of the canonical promoter sequences (Goransson et al, 1990, Higgins et 
al, 1988).  It was shown that the presence of H-NS formed a barrier to gene expression 
that was not easily overcome by either point mutations or small insertions into the regions 
to which H-NS was shown to bind (Schnetz, 1995, Yarmolinsky, 2000).  Furthermore it 
was suggested that silencing occurred as a result of H-NS interacting with sequences 
located both upstream and downstream of the genes studied, and then interacting with 
itself to form looped structures (Schnetz, 1995).  Also, it has been proposed that binding 
of H-NS to DNA affects the superhelicity of bacterial promoters, thereby modulating 
transcription.  H-NS has also been proposed to be an environmental sensing molecule 
modulating gene expression in response to changes in DNA superhelicity as a result of 
temperature, pH, osmolarity, and growth phase (Atlung & Ingmer, 1997, Fang & Rimsky, 
2008, Dorman, 2004,).  While evidence suggests that the relationship between H-NS and 
changes in environmental conditions is complex, it is clear that H-NS is not simply a 
temperature or osmolarity sensor (Fang & Rimsky, 2008).   
 While numerous examples of H-NS induced silencing exist, it is unclear if H-NS can 
act directly as a transcriptional activator.  Accounts of H-NS functioning as an activator 
have been described, for example, in E. coli H-NS has been shown to positively affect 
flagellum biosynthesis (Bertin et al, 1994, Soutourina et al, 1999) and H-NS has been 
shown to act as a positive regulator of pectate-lyase synthesis in the plant pathogen 
Erwinia chrysanthemi (Nasser & Reverchon, 2002).  However in both instances, H-NS is 
functioning indirectly as an activator by directly repressing a repressor, thus eliciting a 
net positive effect.  
 4 
Interaction of H-NS with DNA 
 The ability of H-NS to function at the multitude of promoters as it does, arises from 
the fact that H-NS does seem to bind to just one consensus binding sequence, but rather 
H-NS displays binding affinity for a particular DNA structure; curved DNA (Dame et al., 
2000, Lang et al., 2007, Bouffatrigues et al., 2007, Dorman, 2004, Spassky et al., 1984, 
Zhang et al, 1996, Zuber et al, 1994). Curved DNA is commonly found in promoter 
regions regulated by H-NS (Yamada, 1990, Bracco et al., 1989, Jauregi et al., 2003).   
The intrinsic curvature of promoters can be specified by a variety of DNA sequences 
(Pedersen et al., 2000, Barbic et al., 
2003a), which allows DNA binding 
proteins that recognize such structures 
the ability to interact with a variety of 
promoters, but are often caused by AT 
rich regions of DNA.  DNase I footprint analysis of H-NS binding has demonstrated H-
NS interaction with AT rich DNA time and again (Dame et al, 2005, Dame et al, 2006, 
De la Cruz et al, 2007, De la Cruz et al, 2009, Dorman et al, 1999, Dorman & Deighan, 
2003, Dorman, 2004, Dorman, 2009, Porter & Dorman, 1994, Rimsky et al, 2001, 
Rimsky, 2004, Shi et al, 2004, Stoebel et al, 2008, Williams et al, 1996, Turner & 
Dorman, 2007).  New insights into the transcriptional regulation by H-NS have yielded a 
10 base pair (bp) consensus binding site (Fig. 1) at the osmoregulated E. coli proU 
promoter, which regulates an osmoprotectant uptake locus (Lang et al, 2007).  This site is 
found in two positions downstream of the proU promoter, termed the negative regulatory 
element (NRE).  This binding motif has been proposed to be a nucleation site for H-NS 
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binding.  Upon binding by H-NS, these high-affinity sites are thought to act 
synergistically with lower affinity sites located in the promoter which allows the 
formation of a specific nucleoprotein complex that results in the repression of 
transcription (Fang & Rimsky, 2008, Bouffartigues et al., 2007, Lang et al., 2007).  
While promoters such as the E. coli bgl promoter contains 10 potential such binding sites, 
others like the E. coli nir promoter contain less (Fang & Rimsky 2008), and still some 
promoters contain no such sequence yet bind H-NS in vitro.  Whether the high-affinity 
binding site is present or not, it is clear that upon H-NS binding to DNA, it spreads, or 
oligomerizes, along the DNA, coating it. 
Structure of H-NS 
 To understand how H-NS oligomerizes on DNA one must first understand its 
structure.  While the complete crystal structure of H-NS has not been resolved, proteomic 
analysis (primarily Nuclear Magnetic Resonance [NMR]) has revealed some interesting 
findings regarding H-NS.  The H-NS protein is 137 amino acids in length and is 
comprised of three structural components: an N-terminal oligomerization domain; a C-
terminal DNA binding domain; and a flexible linker that connects the two (Rimsky 2004, 
Dorman 2003, Dorman 2004).  A 46-residue segment of the N-terminal domain was 
found to be required for dimerization (Bloch et al, 2003).  NMR analysis of the E. coli H-
NS protein showed that the resulting structure was an intertwined anti-parallel structure 
that resembled a “handshake” (Bloch et al, 2003).  Interestingly, the same structure from 
the corresponding region of the protein from Salmonella typhimurium showed a parallel 
arrangement (Esposito et al., 2002).  It should be noted that both proteins have identical 
amino-acid sequences, and remains unclear as why both proteins adopt different 
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structural configurations (Esposito et al., 2002, Rimsky, 2004, Dorman, 2000).  The N-
terminal structure of VicH, the H-NS-like protein from Vibrio cholerae, shows similar 
structural features to that derived from E. coli, which highlights the conserved function of 
this region (Cerdan et al, 2003). 
 Unlike differences in the N-terminal domain, the C-terminal nucleic acid binding 
domain remains highly conserved among members of the H-NS family (Tendeng & 
Bertin, 2003).  Mutations in the C-terminal, DNA binding, domain do not impair the 
proteins ability to dimerize, but instead impairs the ability to recognize curved DNA 
(Bloch et al., 2003).  This indicates a role for the C-terminal domain in DNA binding but 
shows that DNA binding activity is dependent upon the N-terminal domain, which allows 
dimerization, initiating the DNA binding event (Dorman, 2004, Ueguchi et al, 1996).  
Experiments using modified H-NS proteins lacking oligomerization properties lack the 
ability to bind DNA, and therefore lack the ability to induce repression.  This supports the 
findings that oligomerization of the protein is required for full activity of H-NS (Rimsky 
et al., 2001, Badaut et al., 2002).  In solution H-NS forms a dimer, although higher 
oligomeric states have been observed dependening upon the concentration of H-NS 
(Smyth et al, 2000, Rimsky, 2004).  The higher-order oligomerization, which is an 
essential function of H-NS, is a function of the flexible linker region of the protein (Bloch 
et al., 2003).  Disruption of the flexible linker region impairs the ability of H-NS to form 
higher-order oligomers, implicating this region in higher-order structure formation 
(Esposito et al., 2002).  
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 H-NS silences transcription by altering DNA topology  
 Based on the structural data available two proposals have been made regarding the 
mechanism of H-NS function. The first proposal, based on the Salmonella typhimurium 
H-NS protein, suggests a role for head-to-tail dimers, where the unstructured flexible 
linker region allows the cross-linking of separate DNA duplexes or different parts of the 
same duplex (Esposito et al., 2002, Dorman 2004) (Fig. 2a).  The second proposal, based 
on the E. coli H-NS protein, suggests that the N-terminal and C-terminal interaction with 
Fig. 2.  From Dorman, 2004, showing two views of H-NS-mediated DNA bridging.  a) H-NS dimer 
interacts simultaneously with two DNA duplexes or different parts of the same duplex through its C-
terminal domains, based on the model by Esposito et al. (2002) for the Salmonella protein showing the N 
terminus lies parallel to the C terminus. b) Two H-NS dimers, each bound to separate DNA duplexes (or 
separate parts of the same duplex) interact with each other via their extended flexible linker regions.  It is 
proposed that extension of the linker region is brought about by simultaneous involvement of the N-
terminal and C-terminal domains in DNA binding.  This model is based on analysis of the E. coli protein 
(Rimsky, 2004).  The promoters within the dimers are shown in dark green and light green.  N = amino-
terminus, C = carboxy-terminus. 
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DNA imposes a more stable structure on the flexible linker, which allows it to interact 
with the flexible linker region of other bound H-NS molecules which results in a higher-
order, cross-linked, nucleoprotein complex being formed (Esposito et al., 2002, Dorman 
2004)(Fig. 2b).  Atomic force microscopic analysis supports this second proposal that H-
NS can cross-link DNA in this manner (Dame et al., 2000).   
 Either mechanism could contribute to the H-NS condensation of DNA.  H-NS has 
also been shown to bind at a region of curvature to which it nucleates, followed by 
oligomerization along the DNA (Amit et al, 2003).  In this model of transcriptional 
silencing the curved sequence to which H-NS binds is located upstream or downstream of 
the promoter, which acts as a nucleating site 
(Rimsky et al., 2001).  The initial 
protein:DNA interaction at a bent region 
induces an intramolecular bridge.  The 
formation of the intramolecular bridge 
further stimulates H-NS mediated bridging of 
the flanking sites resulting in oligomerization 
(Dame et al., 2000).  H-NS oligomerization 
along the DNA in either direction from 
nucleating sites is not in conflict with the 
previously described modes of action for H-
NS, as additional higher-order nucleoprotein complexes could form between multiple 
regions of DNA bound by H-NS separated by un-bound, intervening DNA (Kim & 
Wang, 1999).  Interaction of two sites of H-NS bound DNA has been shown to trap RNA 
Fig. 3. From Mauer et al., 2009. H-NS induced 
plectonemes.  H-NS bound to lambda DNA at a 
ratio of 1 H-NS molecule per 1539 bp.  The two 
DNA duplexes in the H-NS “filament” adopt a 
tightly interwound plectonemic form. 
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polymerase at the promoter, preventing transcription (Dame et al., 2002).  Therefore, the 
regulation of promoter activity is much more complicated involving the arrangement and 
multiplicity of nucleation and propagation sites (Rimsky, 2004), followed by bridging of 
two DNA helices and subsequently, condensation (Dame et al., 2000, Maurer et al, 
2009).   
 The alignment of the H-NS dimers effectively “zippers” the DNA, constraining 
negative supercoils, thus changing DNA topology, which results in transcriptional 
silencing (Rimsky et al., 2001, Tupper et al, 1994).  Nucleoid-associated proteins binding 
to DNA can alter the topology of the DNA into two basic types of coils: either 
plectonemic (interwound) or toroidal (solenoidal) (Maurer et al., 2009).  Binding by H-
NS results in plectonemic (interwound) structures that are capable of covering at least 
1.65 kb (Maurer et al., 2009) (Fig. 3).  Atomic force microscopic analysis of H-NS bound 
DNA, showed that H-NS-DNA complexes were organized into consistent structures and 
that the periodicity of H-NS binding induced structures was approximately every 60 bp of 
DNA (winding two DNA duplexes together, onto themselves) (Maurer et al., 2009).  The 
heat-unstable protein (HU), another NAP, that exists as an octamer, and which has been 
shown to antagonize H-NS, has been measured to bind to approximately 64-68 bp 
(Broyles & Pettijohn, 1986).  This suggests that one conformation (e.g. plectonemic) 
could be easily converted into another (e.g. toroidal) simply by reorganizing the 
nucleoprotein complex by the interaction of a competing protein.  This explains how a 
competing DNA binding protein might function to relieve H-NS induced repression, at a 
mechanistic level.  These tight plectonemic structures stabilized by H-NS are consistent 
with gene silencing and repression (Maurer et al., 2009), therefore, the promoters of the 
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regulated genes should then be located at the nodes where they would remain accessible 
to transcriptional machinery, however, direct evidence for this is lacking (Rimsky, 2004).  
In these topologically closed domains, the plectonemic conformations of the DNA can be 
easily overcome by other NAPs or RNA polymerase (RNAP), as the force with which H-
NS constrains DNA is relatively weak, ~ 7pN while the force generated by RNAP is up 
to 25 pN (Dame et al., 2006, Maurer et al., 2009).  The ease with which these structures 
can be overcome ultimately results in transcription.     
 A plectonemic structure constrained by H-NS, and a simple conversion to a toroidal 
or open conformation, by another DNA binding protein, or a change in DNA 
superhelicity subsequent to changes in osmolarity or temperature (Adler et al, 1989), 
satisfies the requirements that the DNA i) remain accessible to transcriptional machinery 
and ii) maintains the bacterial nucleoid by compacting the DNA (Dame et al., 2006, 
Maurer et al., 2009).  We are beginning to build a more complete mechanistic picture of 
the way in which silencing is achieved.       
H-NS interaction with other nucleoid-associated proteins 
 The oligomerization domain of H-NS is not only important for H-NS:H-NS 
interactions, but also facilitates binding with heterologous proteins that share the same 
domain (Dorman, 2004).  Studies have shown that H-NS can oligomerize with up to five 
different protein species in the H-NS family (Rimsky, 2004, Dorman, 2004).  
Oligomerization by H-NS to other related proteins raise the possibility that the activity of 
these heteromers is altered resulting in additional levels of complexity in gene regulation 
((Dorman & Deighan, 2003), Rimsky, 2004).  The most common of these other 
heterologous proteins is the paralogue StpA (Rimsky, 2004, Dorman, 2004).  StpA has 
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been described as a molecular back up for H-NS, however, it does not always provide 
this function (Dorman & Deighan, 2003).  StpA shares many properties with H-NS 
including, 52% homology, the DNA binding domain, oligomerization domain and a 
flexible linker connecting the two (Zhang et al., 1996, Ueguchi et al., 1996, Williams et 
al., 1996, Spurio et al, 1997, Dorman et al., 2000, Smyth et al., 2000).  Each protein can 
inhibit its own expression as well as the expression of the other protein (cross and 
autoregulation) (Zhang et al., 1996).  It has been proposed that StpA acts as a molecular 
adapter facilitating targeting of H-NS to DNA by multiple protein:protein interactions 
(Free et al, 2001).  Some bacteria express more than one member of the H-NS family, an 
example is Shigella flexneri that expresses 3 members: H-NS, StpA, and Sfh, and all 
three proteins can form oligomeric complexes with each other (Deighan et. al., 2003).  Of 
the H-NS-like proteins studied thus far, all have the ability to form protein:DNA bridges 
(Dame et al., 2005).  The resulting complexes in all theses previously described situations 
leads to transcriptional silencing.   
 H-NS has also been shown to interact with other, more distantly related proteins.  H-
NS interaction has been described with the: FliG flagellar motor protein, Hfq which binds 
RNA and modulates translation of mRNA, Hha a thermo-osmoregulator of the E. coli α-
haemolysin toxin, and the Yersinia enterocolitica Hha homologue YmoA (Donato & 
Kawula, 1998, Dorman, 2004, Nogueira & Springer, 2000, Ellison & Miller, 2006a, 
Ellison & Miller, 2006b, Stoebel et al., 2008).  
 Together, these findings suggest that protein-protein interactions of this nature are 
widespread in gram-negative bacteria.  Interestingly, the genes that encode H-NS-like 
proteins and the Hha-like proteins are found on plasmids acquired by horizontal gene 
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transfer (Dorman, 2004).  One hypothesis for why a plasmid would carry its own H-NS-
like protein is that it appears to protect the recipient cell from the deleterious effects of H-
NS titration by AT-rich sequences and allows the cell to tolerate the plasmid (Doyle et al, 
2007).   
H-NS silences genes acquired by horizontal gene transfer 
 Horizontal gene transfer has been described as one of the primary sources of genetic 
diversity in microorganisms (Jain et al, 2002) and has been most extensively studied in 
the human bacterial pathogens where many virulence factors have been acquired in this 
manner (Hacker & Kaper, 2000).  Acquiring genes through horizontal transfer raises 
some very important regulatory issues, e.g. will the new gene be incorporated 
immediately into existing regulatory circuits?  Will the gene operate independently?  
Foreign sequences are more likely to decrease the fitness of the host rather than 
increasing it (Navarre et al, 2006).  Therefore, incoming, newly acquired sequences must 
be brought under the control of existing cellular regulators, and it is the proteins that 
show the highest degree of promiscuity for promoters that are best adapted to this 
function, e.g. H-NS (Dorman, 2004, Navarre et al., 2006).  The silencing of newly 
acquired genes by H-NS is thought to protect the bacterium from potentially deleterious 
effects of transcribing genes that may compromise their fitness (Navarre et al., 2006).  
Many examples exist in the literature of H-NS mediated silencing of genes acquired by 
horizontal gene transfer, for example the large, 230 kb, virulence plasmid of Shigella and 
enteroinvasive E. coli which carries many of the genes required for virulence, like a type 
III secretion system (t3ss) and genes required for invasion and adhesion (Adler et al., 
1989, Beloin & Dorman, 2003, Beloin et al, 2003, Hromockyj & Maurelli, 1989, 
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Hromockyj et al, 1992, Porter & Dorman, 1994).  Similarly H-NS has been shown to be a 
repressor of the virulence genes associated with the Salmonella SPI-1 pathogenicity 
island, the virulence regulon in Vibrio cholerae, the invasion gene invA of Yersinia, and 
the locus of enterocyte effacement (LEE) pathogenicity island of enteropathogenic E. coli 
(Tupper et al., 1994, Porter & Dorman, 1994, Heroven et al, 2004, Cerdan et al., 2003, 
Nye & Taylor, 2003, Navarre et al., 2006).  It is interesting to note that foreign sequences 
inherited by horizontal gene transfer are rich in adenine and thymine (AT-rich) compared 
to that of their host.  AT-rich sequences are more intrinsically curved (Zuber et al, 1994), 
providing an explanation of how these regulatory circuits have evolved using H-NS, and 
H-NS-like proteins as silencers of transcription (Lucchini et al, 2006, Oshima et al, 2006, 
Navarre et al., 2006).  Although this explains how foreign genes are selectively targeted 
for silencing, the question still remains as to how H-NS silenced genes are to be 
integrated into existing regulatory networks and expressed under appropriate conditions.   
 
1.2 Transcriptional anti-silencing 
  Since transcriptional silencing, is a process that renders appreciable regions of DNA 
inaccessible to proteins such as RNA polymerase (RNAP), DNA modifying enzymes, 
etc., to which it would otherwise be able (Dorman et al., 1999, Yarmolinsky, 2000), the 
mechanism that counters this makes previously inaccessible regions of DNA accessible 
and has been coined anti-silencing.  Anti-silencing differs from true activation in that 
RNAP is not actively recruited to the DNA, with few exceptions e.g. ToxT of V. cholerae 
(Nye et al, 2000).  Anti-silencing can occur through a protein independent, or a protein 
dependent mechanism and often a combination of the two is required for optimal 
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performance.  Therefore, in a protein dependent anti-silencing mechanism, the anti-
silencing protein can be any DNA binding protein that antagonizes, interferes with, or 
alters, the action of a silencing protein, e.g. H-NS.  Protein dependent anti-silencing 
mechanisms generally occur in 3 ways (however, subtle variations in these themes exist, 
and a anti-silencing proteins may function through more than one mechanism): through 
direct competition with the silencing protein (this can include blocking the silencing 
proteins polymerization), through altering the DNA in a way that transcription is allowed 
to occur, and by de-stabilizing the repressive, silenced, DNA structure.   
Protein independent anti-silencing  
 The simplest form of anti-silencing is a protein-independent mechanism which relies 
on the static curvature of the DNA.  The dimerization and bridging characteristic of H-
NS makes the protein uniquely sensitive to DNA structure.  The static curvature of DNA 
can facilitate H-NS cross-linking, but the curvature is also sensitive to environmental 
conditions (De la Cruz et al, 2009, Falconi et al, 1998, Prosseda et al, 2004, Stoebel et al, 
2008).  Any condition that could alter the DNA structure would then antagonize the H-
NS induced bridging.  Conditions that are known to alter the curvature of DNA are 
temperature and osmolarity.  An increase in temperature can reduce the degree of 
curvature thereby reducing the ability of H-NS to constrain the bridged structure (Rohde 
et al, 1999, Ussery et al, 1999), as observed in the case of the promoter of the virF 
virulence gene in Shigella flexneri (Prosseda et al., 2004).  Likewise a change in 
osmolarity can also affect DNA curvature. The E. coli proU promoter, which is 
negatively regulated by H-NS, is sensitive to changes in DNA superhelicity following 
osmotic shock, which effects H-NS binding to its regulatory regions (Bouffartigues et al., 
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2007).  Environmentally induced changes in DNA curvature might represent the most 
fundamental mechanism of transcriptional anti-silencing, but more complex mechanisms 
of anti-silencing exist in the literature.      
 Many horizontally acquired elements encode genes for protein antagonists of H-NS, 
including Ler, Lrp, Fis, IHF, HU etc., and many of them share degenerate target 
specificities, as H-NS does, making them ideal regulators involved in either, competition 
for binding sites in DNA, or remodeling the architecture of the DNA that has a positive 
effect on transcription (Dorman, 2004, Fang & Rimsky, 2008, Navarre et al, 2007, 
Stoebel et al., 2008).          
Protein dependent anti-silencing: direct competition 
 The protein dependent mechanism underlying transcriptional silencing/anti-silencing 
has been proposed to be a straightforward molecular antagonism involving direct 
competition between H-NS and other sequence specific DNA binding proteins for their 
overlapping cognate DNA binding sequences (Fang & Rimsky, 2008, Navarre et al., 
2007).  Examples of anti-silencing being a straightforward antagonism exist at a variety 
of bacterial promoters, e.g. SlyA counters H-NS silencing of the hemolysin gene hlyE in 
E. coli through direct competition, similarly RovA from Yersinia counters H-NS 
silencing of the invasin inv, and the urease gene activator UreR of Proteus mirabilis 
displaces H-NS by directly competing for essential binding sites (Coker et al, 2000, 
Ellison & Miller, 2006a, Ellison & Miller, 2006b, Westermark et al, 2000, Heroven et al, 
2004, Heroven et al, 2007, Lithgow et al, 2007, Poore & Mobley, 2003).  The ToxT 
transcription factor from Vibrio cholerae antagonizes H-NS at two promoters by direct 
competition (Nye et al., 2000).  In Salmonella, many of the genes regulated by SlyA are 
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likely to have been acquired by horizontal gene transfer, and all but one of these is 
repressed by H-NS (Navarre et al., 2005, Navarre et al., 2006).  A mutual antagonism 
exists between SlyA and H-NS where one protein is able to displace the other depending 
on relative concentrations of the two proteins.  This could represent one mechanism for 
the re-establishment of H-NS mediated repression by allowing both proteins to utilize 
similar mechanisms, allows fine-tuning of transcription in the cell (Lithgow et al., 2007).  
This mechanism may be more common among silencing and anti-silencing proteins and 
is unlikely restricted to SlyA and H-NS.  Still another mechanism of counter-silencing by 
direct competition has been observed where two proteins of E. coli, PapB and CRP, 
appear to work in tandem to antagonize H-NS mediated silencing of the pap promoters 
(Forsman et al, 1992).  
Protein dependent anti-silencing: alteration of topology 
 In contrast, at some bacterial promoters the anti-silencing proteins function to alter 
the DNA topology in a way that no longer allows H-NS to constrain transcription.  For 
example, LeuO counters silencing of the quiescent porin ompS1 in Salmonella by altering 
the topology of the ompS1 promoter region (De la Cruz et al, 2007, De la Cruz et al, 
2009) and in Shigella flexneri, VirB antagonizes H-NS by affecting the structure of the 
icsB promoter (Turner & Dorman, 2007).  The mechanism by which this is achieved 
involves protein binding to specific binding sites followed by propagation of the protein 
along the DNA with associated wrapping of the DNA.  H-NS is no longer able to 
maintain the repression complex, which allows RNAP to access the DNA and initiate 
transcription (Beloin & Dorman, 2003, De la Cruz et al., 2009).  Interestingly, the SlyA 
protein of Salmonella, which directly competes with H-NS at the hlyE promoter, 
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functions to remodel the architecture of the DNA at the ugtL and pagC promoters (Kong 
et al, 2008, Perez et al, 2008, Shi et al, 2004).  LeuO has also been shown to block H-NS 
propagation by binding between the H-NS upstream and downstream binding sites, 
functioning as a boundary element (Chen & Wu, 2005, Chen et al, 2005).  These results 
show that a single H-NS antagonist can function via two distinct mechanisms: by direct 
Fig. 4. Adapted from Stoebel et al., 2008.  Illustration of the ways in which a repressive H-NS 
promoter complex (a) can be modified to permit transcription.  At certain promoters (b), specific 
de-repression occurs via a protein-independent mechanism involving environmentally induced changes 
in DNA bending or supercoiling (colored arrow).  Many promoters are de-repressed via promoter-
specific DNA-binding proteins (black arrows), which can work by preventing H-NS oligomerization 
along the DNA (c), displacing H-NS, or modifying the conformation of the promoter, or both while 
some H-NS remains bound (d), or displacing H-NS, by direct competition for H-NS binding regions 
(e).  Other de-repression mechanisms are general for many H-NS repressed promoters (grey arrows).  
These include weakening the H-NS-promoter complex (H-NST)(f), or expression of an H-NS 
paralogue (discussed in “silencing;” see above) that may enhance repression or alter its sensitivity to 
other de-repression mechanisms dependent upon the exact properties of the protein-DNA complex (g).    
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competition, and remodeling the nucleoprotein complex (Stoebel et al., 2008).  The 
common feature that is shared by the H-NS antagonizing proteins is that most, if not all, 
bind to AT-rich sequences, which may explain why these proteins have evolved to 
function as anti-silencers (Navarre et al., 2006).  
Protein dependent anti-silencing: destabilization 
 A third mechanism of counter-silencing, that is not often described, is the use of 
truncated H-NS molecules (H-NST).  The genes encoding these molecules have been 
found in pathogenicity islands of pathogenic E. coli strains (Williamson & Free, 2005).  
H-NST molecules show homology to the H-NS oligomerization domain, but lack nucleic 
acid binding and linker regions (Willamson & Free, 2005).  As opposed to the sequence-
specific proteins directly competing with H-NS for binding to DNA, or remodeling the 
nucleoprotein complex, H-NST molecules interfere with H-NS oligomerization and is 
thought to weaken the ability of H-NS to form bridges by replacing full length H-NS.  
However, the biologic significance of H-NST molecules remains unclear and examples 
have not been demonstrated outside of the pathogenic E. coli strains (Navarre et al., 
2006, Stoebel et al., 2008, Williamson & Free, 2005). 
  
1.3 Shigella, the bacterial pathogen 
 
 Shigella species are gram-negative intracellular pathogens that cause bacillary 
dysentery in humans.  Shigella infections are responsible for approximately 164 million 
infections each year resulting in 1.1 million deaths, most of these occur in developing 
countries and in children less than 5 years old (Kotloff et al, 1999, Lee et al, 2005, Li et 
al, 2009).   The genus is divided into 4 species, Shigella flexneri, Shigella boydii, Shigella 
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sonnei, and Shigella dysenteriae.  The species are further divided into serotypes based on 
biochemical differences and variations in their O-antigens, such that, Shigella flexneri is 
further divided into 13 serotypes.  Shigella flexneri is endemic in most developing 
countries and causes more mortality than any of the other Shigella species (Bennish & 
Wojtyniak, 1991).  Of the 13 serotypes of S. flexneri serotypes 1b, 2a, 3a, 4a, and 6 are 
predominant in developing countries, while 2a is predominant in industrialized countries 
including the United States (Kotloff et al., 1999).   
Shigella pathogenicity 
 The mechanism of pathogenicity of Shigella flexneri is based on the capacity of the 
organism, once ingested, to reach the colonic mucosa and to invade the colonic epithelial 
cells.  Invasion of the epithelial cells leads to intracellular bacterial multiplication, spread 
to adjacent cells, cell death, and eventually inflammation and ulceration of the colonic 
mucosa (Hale, 1991).  This pathogenicity is a complex phenomenon, which relies on the 
coordinated expression of a suite of genes, many of which are found on the large (230 
kbp) virulence plasmid. The structural genes required for invasion, including a type III 
secretion system (t3ss), and the intracellular spread of Shigella in host cells are encoded 
by separate regions of the virulence plasmid: the ipa-mxi-spa locus and the icsA gene 
(Dorman & Porter, 1998).  The large virulence plasmid carries genes encoding key 
virulence gene regulators. Further regulators of virulence gene expression in Shigella are 
located on the chromosome: the plasmid-located positive transcriptional regulators virF 
and virB and the chromosomally encoded negative regulator hns (Adler et al., 1989, 
Dagberg & Uhlin, 1992).   
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The regulatory cascade controlling Shigella virulence 
 The VirF and VirB proteins act in a cascade to activate virulence gene promoters in 
response to environmental stimuli that indicate the bacterium is in the appropriate 
location in the host.  Temperature is a key regulatory factor of virulence gene 
transcription, since virulence gene transcription is repressed at temperatures below 37 ℃.  
H-NS has been shown to direct the temperature-regulated expression of virulence genes 
by repressing their transcription during growth at 30 ℃ (Dorman et al., 1990, Hromockyj 
et al., 1992).  At the non-permissive temperature of 30 ℃, H-NS binds to two sites 
within the virF promoter (Fig.5). The two regions of bound H-NS interact in the 
formation of a nucleoprotein complex that results in repression of virF transcription.  An 
increase in temperature to 37°C, antagonizes the DNA topology resulting in the loss of 
contact between the H-NS regions and this is thought to de-stabilize the nucleo-repressive 
complex resulting in de-repression and subsequent transcription of the virF gene   
(Falconi et al., 1998, Prosseda et al., 2004). 
Fig. 5. From Dorman, 2004.  H-NS mediated repression of the virF virulence-gene promoter 
in Shigella flexneri.  At the S. flexneri virF promoter, there are two binding sites for the H-NS 
protein centered at -1 and -250 with respect to the transcriptional start site, which is shown with an 
angled arrow.  Formation of the repression complex at low temperatures requires looping of the 
intervening DNA.  The formation of a DNA topology that is conducive to repression is antagonized 
by increased temperature.  The resulting loss of contact between the bound H-NS proteins is 
thought to result in the instability of the nucleoprotein complex at the virF promoter, leading to 
derepression of transcription (Falconi et al., 1998)   
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The major transcriptional activator VirF   
 Once expressed, VirF, an AraC-like transcription activator, binds directly to the virB 
promoter.  Tobe et al. (1995) have shown that VirF is present in vivo at both permissive 
and non-permissive temperatures (although transcription of virF at 30 ℃ is one quarter 
of that at 37 ℃ at which maximal transcription occurs) and that it can that it can bind in 
vitro to the virB promoter at both temperatures.  Therefore, the thermal activation signal 
is not just production of VirF.  These findings suggest that an increase in temperature 
results in a change in DNA supercoiling that is responsible for the VirF dependent 
activation of the virB promoter.  Porter & Dorman (1997) also showed that virB DNA 
topology was affected by changes in osmolarity and pH resulting in increased negative 
supercoiling.  Therefore, the alteration in DNA topology facilitates a productive 
interaction between bound VirF and RNA polymerase and also raises the possibility that 
a change in supercoiling may promote VirF oligomerization on the DNA, which results in 
the antagonism of H-NS leading to transcription of virB (Fig. 5)(Dorman & Porter, 
1998).     
Fig. 6.  The regulatory cascade controlling Shigella virulence.  At the non-permissive temp of 30 ℃ 
H-NS causes repression of the major transcription factors virF and virB.  Upon a shift in temperature to 
the permissive temp of 37 ℃ a change in DNA topology relieves the H-NS induced repression of virF.  
VirF antagonizes the H-NS induced repression of the virB promoter and subsequently VirB alleviates the 
H-NS dependent repression of many virulence plasmid genes including those of the invasion locus; the 
type III secretion system shown here is representative.  
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 Subsequently, VirB alleviates H-NS dependent repression of many virulence plasmid 
genes, including those of the invasion locus ipa, mxi, and spa; virA, ospB and phoN2 
(Beloin & Dorman, 2003, Berlutti et al, 1998, Maurelli et al, 1984a, Maurelli et al, 
1984b, Maurelli & Sansonetti, 1988, Nicoletti et al, 2008, Prosseda et al, 1998, Sasakawa 
et al, 1993, Tobe et al, 1991, Tobe et al, 1993, Tobe et al, 1995, Dorman, 2006, 
Hromockyj et al., 1992, Porter & Dorman, 1994, Porter et al., 1998, Prosseda et al., 
1998). 
The major transcriptional activator VirB: an unusual transcriptional regulator 
 The VirB protein 
was first identified 
through transposon 
mutagenesis of the 
large virulence 
plasmid, when it was 
shown to be essential 
for the expression of 
almost all the 
structural virulence 
genes (Watanabe et al, 1990).  VirB is an unusual candidate for a transcriptional activator 
sharing no homology to previously described conventional transcriptional activators.  
Instead, VirB shares considerable homology with a family of plasmid partition proteins, 
including ParB and SopB, proteins that are involved in the plasmid partition and 
maintenance of stable plasmid copy number in P1/P7 and F plasmids, respectively (Fig. 
Fig. 7. From  Beloin et al.,2002.  Model of VirBs functional 
and structural domains.  A structural model of VirB deduced 
from experiments performed in Beloin et al., 2002.  Below is the 
structural model of the ParB protein based on the work of 
Surtees & Funnell, 1999,2001. In ParB, DRS, represents 
“discriminator recognition sequence,” implicated in the DNA 
binding activity of ParB.  
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7)(Watanabe et al., 1990, Abeles et al, 1985, Bignell & Thomas, 2001).  VirB is small, 
32 kDa, and basic and has been shown to form dimers, trimers, and higher order 
oligomers in vitro and in vivo (Beloin et al, 2002).  VirB can oligomerize independent of 
DNA binding and occurs through two domains, a leucine zipper, and a C-terminal 
domain predicted to form a triple coil structure (Beloin et al., 2002).  
VirB shows homology to the partition proteins SopB/ParBVirB interacts with DNA in 
vivo and is dependent on the presence of the N-terminus and the integrity of the helix-
turn-helix (HTH) binding motif.  The HTH was found to be essential for structural gene 
activation (Beloin et al., 2002).  The HTH DNA-binding motif in VirB is 80% identical 
to the HTH in the homologous ParB protein, which mediates the binding of ParB to parS 
which leads to plasmid partitioning (Beloin et al., 2002, Lobocka & Yarmolinsky, 1996, 
Surtees & Funnell, 2001).      
 Beloin et al. (2002) showed that the leucine zipper (LZ) motif was essential for VirB 
to form oligomers, and that oligomerization was essential for the VirB dependent 
activation of a mxiC-lacZ fusion.  Complete loss of the LZ resulted in complete loss of 
the ability of VirB to activate gene expression and reduces its ability to bind DNA 
Fig. 8. From Surtees & Funnell, 2001. The parS site.  tall and short boxes outline the box A and box 
B sequences respectively, and the black line shows the IHF binding site. 
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(Beloin et al., 2002).  However, the LZ cannot promote protein:protein interactions in 
isolation, instead it requires the C-terminal domain (Beloin et al., 2002).  Therefore, the 
LZ most likely functions to promote oligomerization, which is then stabilized by the C-
terminal coiled-coil 
structure, making both 
regions mutually dependent 
on one another  
(Boss et al, 1999, Beloin et 
al., 2002).  Also, the HTH 
motif was found to be 
essential in DNA binding 
but did not contribute 
significantly to VirB oligomerization (Beloin et al., 2002, (McKenna et al, 2003).  The 
work of Beloin et al.(2002), and later McKenna et al. (2003), demonstrated that VirB is a 
direct DNA binding protein that interacted specifically with the promoters of the 
virulence genes its known to regulate.  They also demonstrated the necessity of VirB 
oligomerization in the activation of the structural genes, a situation that resembles the 
homologous ParB and SopB functions (Beloin et al., 2002, McKenna et al., 2003).  ParB 
oligomerization, which ultimately leads to protein:DNA bridges via protein:DNA and 
protein:protein interactions, is an essential step in the formation of the partition complex 
to effectively segregate plasmids (Bouet et al, 2000, Schumacher & Funnell, 2005, 
Schumacher et al, 2007).  Even though VirB shows homology to ParB and SopB there is 
no data to support that VirB is involved in plasmid partitioning or maintenance of the 
Fig. 9.  From Taniya et al., 2003.  Comparison of the putative 
InvE binding regions in S. sonnei.  Beloin et al., (2002) 
revealed that InvE (VirB) binds to the regions upstream of these 
genes (icsB, spa-15, and virA) specifically.  The numbers 
indicate the positions of these regions (translation start site of 
each gene as nucleotide +1).  The boxes indicate the position of 
the ParB BoxA-like sequence.  The solid arrows indicate the 
direction of each gene transcription. 
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modern virulence plasmid (McKenna et al., 2003, Harrison et al., unpub. data). While 
there is structural homology between VirB and ParB/SopB, there are functional 
differences. Firstly, ParB represses transcription (by spreading along the DNA for great 
distances eg. 2 kb)(Lobocka & Yarmolinsky, 1996, Rodionov et al., 1999), while VirB 
activates transcription by alleviating transcriptional repression (Beloin et al., 2002). 
Secondly, ParB binds to a well defined parS site of plasmid P1 (Fig. 8) which consists of 
4 box A sequences (heptameric) and 2 box B sequences (hexameric) imperfect repeats, 
separated by an integration host factor (IHF) binding site (Surtees & Funnell, 2001), in 
contrast VirB binds to a sequence that is homologous to the box A motif in the parS site, 
and this site in the S. sonnei icsB promoter is essential for the expression of the ipa 
operon.  Based on a previous study in S. flexneri (Beloin et al., 2002) which showed VirB 
(InvE) binding to various promoter sequences, Taniya et al. (2003) also found this 7 bp 
ParB box A-like sequence [5’-(A/G)(A/T)G(G)AAAT-3’] in 2 additional promoter 
sequences (Fig. 9).  In fact this sequence was shown by gel shift assay to be required for 
InvE binding (Taniya, et al., 2003).  This work was further corroborated by Turner & 
Dorman (2007) which showed that VirB bound to a regulatory region within the 
divergently transcribed S. flexneri icsB-ipgD promoter that contained a near-perfect, 
inverted repeat, which is homologous to the parS box A sequence (labeled box 1 and box 
2) (Fig. 10).  However, in Turner & Dorman (2007), only the promoter distal binding site 
(box 2) was found to be critical for the VirB-mediated activation of the promoter.  
Interestingly, the icsB regulatory region shows DNA sequence homology to the parS site 
of plasmid P1 and P7, and furthermore, icsB shares a dependency, as does parS, on the 
IHF protein (IHF has been shown to bind and enhance activity of the icsB promoter; IHF 
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is required for full activation of virF and virB) (Turner & Dorman, 2007, Porter & 
Dorman, 1997).  Together, these findings suggest that VirB is likely to be specific for the 
promoters that contain this box 2 element, or at least close matches to it.  The 
significance of this finding suggests that VirB is a former plasmid partitioning protein 
that has been conscripted to perform a new function, that of an anti-silencer, antagonizing 
the H-NS mediated repression of promoters (Turner & Dorman, 2007).  Unlike the 
ParB/parS system, the virulence plasmid of Shigella does not encode for a partner protein 
for VirB that is equivalent to ParA.  The ParA protein is an accessory ATPase that 
interacts directly with ParB bound at parS and is required for the proper localization of 
Fig. 10. From Turner & Dorman, 2007. Comparison of icsB  and parS.  A) alignment of the icsB 
regulatory region with the parS sequences of phages/plasmids P1 and P7.  The DNA sequence of the 
promoter-distal portion of the icsB regulatory region that contains boxes 1 and 2 is aligned with the 
parS sequences of phages/plasmids P1 and P7.  The converging horizontal arrows show the inverted 
repeats associated with boxes 1 and 2.  The four heptameric and two hexameric parS motifs involved 
in ParB protein interaction are boxed by solid- and dotted-line rectangles, respectively.  Downward-
pointing arrowheads indicate residues within the hexamers that allow ParB proteins to distinguish 
different parS sequences.  The asterisks indicate residues that are conserved between the icsB 
regulatory region and the parS sequences.  B) Genetic map of the portion of the large virulence 
plasmid showing the relative locations of the virB gene and the regulatory sequences of the icsB-ipg-
ipa-acp operon.  The angled arrows represent promoters.  The relative positions of the box 1 and box 
2 motifs upstream of the icsB promoter are shown.  The diagram is not drawn to scale. 
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the ParB-parS complexes, although it is not known how this positioning is accomplished 
(Bouet & Funnell, 1999).  Although, it is possible that another protein interacts with 
VirB, by binding the N-terminal domain of VirB, as proposed in the work of Beloin et al. 
(2002) to date no such co-factor has been found.  Future investigations may one day find 
an accessory protein for VirB. 
VirB function 
 The mechanism by which VirB activates transcription is not completely understood.  
At the icsB promoter, VirB has been reported to bind and oligomerize on DNA to a short 
sequence [5’-(A/G)(A/T)G(G)AAAT-3’] located upstream of the promoter, and this 
binding is required for activity of this promoter (Beloin et al., 2002, McKenna et al., 
2003, Taniya et al., 2003).  However, this sequences occurs 56 times on pWR100 of 
Shigella flexneri, including within numerous insertion sequences scattered along the 
plasmid, and many more (more than 1000 times) with one mismatch, suggesting that this 
sequence alone does not define the VirB target (Le Gall et al, 2005).  An examination of 
all the genes under the control of VirB show a lower G+C content, compared to the host, 
therefore, bending might be an essential part of the VirB recognition motif (it should be 
noted that not all promoters with low G+C content are under the control of VirB) (Le 
Gall et al., 2005).  It has been shown that the promoters under the positive transcriptional 
control of VirB are also under the negative transcriptional control of H-NS, and that VirB 
has been shown to displace H-NS from these promoters (Turner & Dorman, 2007, Beloin 
et al., 2003).  This further strengthens the case for curvature of DNA playing an 
important role in the VirB dependent activation of the promoters for which it regulates.   
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 These studies, and many more, all point to a finely tuned mechanism of regulation 
involving the H-NS mediated repression of the virulence system in S. flexneri, that would 
not be permitted to be expressed until the appropriate environmental signals initiate a 
regulatory cascade involving VirF and VirB, that would limit the wasteful expression of 
the type III secretion system, its effector proteins and additional factors until authentic 
contact with host.  However, many more questions remain to be answered, e.g.; What are 
the full repertoire of genes under the control of VirB?  How does VirB alleviate H-NS 
mediated repression of promoters?  Does VirB have more than one mechanism, which 
can be employed to alleviate H-NS repression?  Is there a better-defined VirB binding 
motif?  An enhanced understanding of the silencing/anti-silencing mechanisms that 
control expression of virulence genes in Shigella, and many other bacteria, is central to 
understanding pathogenesis. 
             
1.4 Objectives of this study 
 The aim of this work is to determine the role that H-NS and VirB play in the 
regulation of the icsP promoter and to examine the molecular mechanism of silencing 
and anti-silencing.  This dissertation is divided into three main chapters encompassing 
five objectives. 
 
Objective 1: To determine regions of the icsP promoter needed for H-NS induced 
repression and regions required for VirB dependent de-repression.  This objective  is    
addressed in chapters 2 and 3. 
 
 29 
 Objective 2: To demonstrate H-NS and VirB bind directly to the icsP promoter.  
 This objective is addressed in chapters 3 and 4. 
 Objective 3: To determine the sequences to which H-NS and VirB bind.  This 
 objective is addressed in chapters 3 and 4. 
 
Objective 4: To examine the effect that icsP static DNA curvature plays in the ability 
of H-NS and VirB to regulate promoter activity.  This objective is addressed in 
addressed in chapter 4.     
 
Objective 5: To propose a mechanism for the H-NS and VirB regulation of the icsP 
promoter.  This objective is addressed in all chapters and model is presented in 
chapter 5. 
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CHAPTER 2 
VIRB ALLEVIATES H-NS REPRESSION OF THE ICSP PROMOTER IN SHIGELLA 
FLEXNERI FROM SITES OVER 1 KB UPSTREAM OF THE TRANSCRIPTION 
START SITE 
Abstract  
The icsP promoter of Shigella spp. is repressed by H-NS and derepressed by the VirB. 
An inverted repeat located between -1144 and -1130 relative to the transcription start is 
required for VirB dependent de-repression of the icsP promoter. The atypical location of 
this cis-acting site relative to the promoter is discussed. 
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2.1 Introduction  
Shigella species are gram-negative intracellular pathogens that invade cells of the 
lower intestinal epithelia of humans and primates, causing bacillary dysentery.  All 
Shigella species carry a large virulence plasmid, and many genes carried by these 
plasmids are thermo-regulated.  At a non-permissive temperature of 30°C, the global 
regulator H-NS (histone-like nucleoid structuring protein) represses transcription of 
many virulence plasmid genes (Beloin & Dorman, 2003, Porter & Dorman, 1994, 
Hromockyj et al, 1992).   At the permissive temperature of 37°C, H-NS dependent 
repression is relieved by temperature induced changes in DNA topology (Falconi et al., 
1998, Prosseda et al., 1998), VirF, or its subordinate regulator VirB (InvE) (reviewed in 
reference Porter & Dorman, 1997).  The mechanism that leads to the alleviation of 
transcriptional repression by H-NS has been coined “anti-silencing.”  Anti-silencing is 
thought top play an important role in controlling the expression of genes acquired 
through horizontal gene transfer and is common in bacterial pathogens in which a 
variety of transcription factors function to relieve repression by H-NS (reviewed in 
reference Stoebel et al., 2008). 
The icsP (sopA) gene is carried on the large virulence plasmid in all Shigella species 
(Egile et al, 1997, Shere et al., 1997) and encodes an outer membrane protease, which 
belongs to the omptin protease family (Hritonenko & Stathopoulous, 2007, Kukkonen & 
Korhonen, 2004) and cleaves the actin-tail assembly protein IcsA from the surface of 
Shigella (Egile et al, 1999, Shere et al., 1997, Steinhauer et al., 1999).  Previous studies 
have revealed that icsP, like other Shigella virulence plasmid genes, including  virA, 
ospB and phoN2 and those of the invasion locus ipa, mxi, and spa (Adler et al, 1989, 
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Berlutti et al, 1998, Beloin et al., 2002, Sakai et al., 1988, Santapaola et al., 2006, 
Taniya  et al., 2003, Tobe et al., 1991, Uchiya et al., 1995) is repressed by H-NS and de-
repressed by VirB (Wing et al., 2004).  In this study, we identify sequences upstream of 
the icsP gene necessary for de-repression by VirB, with a view to improve our 
understanding of the mechanism of transcriptional anti-silencing at the icsP promoter.  
2.2 Materials and Methods  
Bacterial strains, plasmids and media.  
 The bacterial strains and plasmids used in the present study are listed in Appendix 1. 
Bacteria were grown routinely at 37°C in Luria-Bertani (LB) broth with aeration or on 
LB agar (LB broth containing 1.5% [wt/vol] agar).  Antibiotics, as needed, were added to 
achieve the following final concentrations: ampicillin, 100 µg/ml; chloramphenicol, 25 
µg/ml; kanamycin, 50 µg/ml; and tetracycline, 12.5 µg/ml.  Where appropriate, to ensure 
that Shigella strains had maintained the large virulence plasmid during manipulation, 
Congo Red binding was tested on Trypticase Soy Agar (TSA) plates containing 0.01% 
(wt/vol) Congo Red (Sigma Chemical Co., St. Louis, Mo.).   
Construction of the PicsP-lacZ reporter plasmid and truncated promoter fragments. 
 The starting point for this work was the PicsP-lacZ reporter plasmid pHJW7 
(described in Wing et al, 2004; Table 1).  pHJW7 carries a PstI XbaI DNA fragment that 
contains 1232 bp upstream of the transcription start site of the icsP promoter and the first 
48 bp of the icsP coding region.  This fragment is cloned upstream of a translation stop 
site and a promoterless lacZ gene, so that expression of lacZ is directly regulated by the 
icsP promoter.  To facilitate the construction of a series of PicsP-lacZ fusion plasmids, a 
second XbaI restriction site located downstream of the lacZ gene in pHJW7 was removed 
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using the ‘mega’-primer PCR method (Perrin & Gilliland, 1990) with oligonucleotides 
W1016-1018 (Appendix 1).  The resulting plasmid, pHJW20 (Table 1), contains a unique 
XbaI site upstream of the lacZ gene. icsP promoter fragments were PCR amplified from 
pHJW20 using oligonucleotide W89 in combination with each of the following 
oligonucleotides: W44, 45, 46, 47, 528, 529 or 530 (Appendix 1).  PCR products were 
digested with PstI and XbaI, and were ligated into pHJW20 that had also been digested 
with PstI and XbaI.  This created a series of PicsP-lacZ fusion plasmids containing 
promoter fragments lengths of 1056 bp, 893 bp, 665 bp, 351 bp, 254 bp, 150 bp, and 92 
bp, respectively.  These plasmids were called pJS01, pJS02, pDH01, pJS04, pHJW34, 
pHJW35 and pHJW36, respectively (Appendix 1).  
To create pMIC01, pHJW20 was digested with SalI and PstI, treated with T4 DNA 
polymerase and self-ligated using the blunt-ended ligation protocol supplied with T4 
DNA ligase (Promega).  To create pMIC02, a 200 bp fragment was amplified by PCR 
from the virulence plasmid of the S. flexneri strain 2457T using oligonucleotides W81 
and W82 (Appendix 1).  The product was digested with SalI and PstI and the resulting 
fragment was ligated with pHJW20 that had also been digested with SalI and PstI.  This 
created a PicsP-lacZ fusion carrying 1473 bp of sequence naturally found upstream of the 
icsP transcription start site.  The promoterless reporter plasmid pMIC21 was created by 
removing the entire icsP promoter from pHJW20.  To do this, pHJW20 was digested with 
PstI and XbaI, the resulting DNA was treated with T4 DNA polymerase and self-ligated 
using the blunt-ended ligation protocol supplied with T4 DNA ligase (Promega).  The 
sequence of all truncated promoters fragments was confirmed after cloning.  All plasmids 
are described in Appendix 1.   
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In silico analyses of the icsP promoter and upstream sequences.  
 Curvature predictions of the icsP promoter and upstream sequences were performed 
using the bend.it® program (http://www.icgeb.org/dna/bend_it.html.  The curvature is 
calculated as a vector sum of dinucleotide geometries (roll, tilt and twist angles) using the 
BEND algorithm (Goodsell & Dickerson, 1994) and expressed as degrees per helical turn 
(10.5°/helical turn = 1°/bp). Experimentally tested curved motifs produce curvature 
values of 5–25°/helical turn, whereas straight motifs give values below 5°/helical turn.  
To analyze sequences upstream of the icsP tss, the program “Clone Manager 9, Basic 
Edition” (Scientific and Educational Software) was used.  Open reading frames (ORFs) 
greater than 50 amino acids were identified using the “ORF search” feature and the 
“Open Reading Frame analysis” feature was used to predict whether ORFs were coding 
regions.  The “Open Reading Frame analysis” feature uses Fickett's TESTCODE 
algorithm (Fickett, 1982) to generate a score that can help to determine whether or not 
an ORF is likely to be a protein coding region and is based on the observed asymmetry 
of base utilization within coding regions.  ORFs with scores over 0.95 are predicted to 
be coding regions.  To predict whether predicted coding regions identified by our search 
were linked to possible promoter sequences, the BPROM program (Softberry) was used.  
This algorithm predicts potential transcription start positions of bacterial genes regulated 
by sigma70 promoters (major E. coli promoter class).  Linear discriminant function 
combines characteristics describing functional motifs and oligonucleotide composition 
of these sites.  BPROM has an accuracy of E. coli promoter recognition of about 80%. 
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Site-directed mutagenesis of upstream putative VirB-binding sites.  
 The two upstream putative VirB-binding sites were mutated using site-directed 
mutagenesis by PCR using a two step procedure, as described previously (Lie & Leigh, 
2007) using primers listed in Table 2.  In the first step, the 5’ binding site and the 3’ 
binding site were amplified in two separate PCRs. To amplify the 5’ binding site, a 
reverse oligonucleotide, either mutagenic (W100) or complementary to the wild-type 
sequence of the putative VirB-binding site (W99), was used with a forward primer 
(W98).  To amplify the 3’ binding site a forward primer, either mutagenic (W110) or 
complementary to the natural sequence of the putative VirB-binding site (W101), was 
used with a reverse primer (W89).  These reactions created four products: a 5’ binding 
site with wild-type sequence; a mutated 5’ binding site; a 3’ binding site with wild-type 
sequence and a 3’ mutated binding site.  All PCR products were gel purified and treated 
with Promega T4 DNA polymerase (as per manufacturer’s instructions) to remove 3’ 
overhanging nucleotides.  In the second stage of the procedure, the PCR products were 
ligated together in three different combinations using Promega T4 DNA ligase (as per 
manufacturer’s instructions): wild-type 5’ sequences were ligated to mutagenic 3’ 
sequences, mutated 5’ sequences were ligated to wild-type 3’ sequences, and mutated 5’ 
sequences were ligated to mutated 3’ sequences.  Where necessary, 5' phosphates were 
incorporated during oligonucleotide synthesis (Appendix 1).  The resulting ligations 
were used as template in a second round of PCR using oligonucleotides W89 and W98. 
This PCR allowed the amplification of correctly oriented promoter fragments.  Correctly 
sized PCR products were then gel purified and digested with PstI and BglII.  The 
resulting DNA fragments were cloned into a pHJW20 PstI BglII vector to give pMIC13, 
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pMIC17 and pMIC18.  The sequence of all mutated promoters fragments was confirmed 
after cloning.   
Quantification of icsP promoter activity using the PicsP-lacZ reporter and 
derivatives.  
 To measure promoter activities the PicsP-lacZ fusion plasmids described in this work 
were introduced into S. flexneri and E. coli strains by electroporation.  Activities of the 
icsP promoter constructs were determined by measuring β-galactosidase activity as 
described previously (Wing et al, 2004), using the Miller protocol (Miller, 1972).  
Overnight cultures were diluted 1:100 and grown for 4 to 5 h in either TSB medium (S. 
flexneri) or LB (E. coli) at 37°C, prior to cell lysis.  Routinely, β-galactosidase levels 
were measured in early stationary phase cultures grown from three independent 
transformants because experiments had shown that icsP expression significantly 
increases under these conditions (data not shown).  
2.3 Results and Discussion  
 Identification of sequences required for VirB dependent regulation of icsP 
promoter 
Previous work has demonstrated that VirB regulates an PicsP-lacZ fusion integrated 
into the icsP locus on the Shigella virulence plasmid (Wing et al., 2004).  To identify 
regions upstream of the icsP gene that mediate VirB dependent de-repression, a nested 
set of promoter deletions was created (Fig. 2A) and cloned into a medium-copy-number 
lacZ reporter pHJW20 (Appendix 1) to replace the existing 1,232 bp icsP promoter 
fragment.  This created a set of eight PicsP-lacZ fusions whose upstream limits varied 
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from -1232 to -92 relative to the previously annotated transcription start site of the icsP 
gene (Egile et al, 1997) (Fig. 11A; Appendix 1).  
 Each promoter construct was introduced into wild-type Shigella 2457T and a mutant 
derivative, AWY3 (virB::Tn5), and β-galactosidase production was measured using the 
Miller protocol (Miller, 1972).  Of the eight promoter fragments tested, only one 
displayed a >2-fold increase in the presence of VirB (Fig. 12).  Surprisingly, this was the 
longest promoter fragment (found in pHJW20).  The activity of this promoter fragment 
was 17-fold higher in the presence of VirB than its absence.  This increase was unlikely 
to be caused by sequences in the pACYC184 plasmid backbone, because these  
 
Fig. 11.  Promoter elements of the icsP promoter and schematic representation of the truncated 
promoter series.  (A) Angled arrows represent the icsP transcriptional start site (+1), determined 
previously (Egile et al., 1997). The -10 and -35 hexamers are boxed and shown in bold. The 
translational start site is represented by an open arrow. The truncated promoters are drawn to scale 
and numbers represent the upstream boundary of the icsP promoter, relative to the tss (+1). The 
promoter fragments represented are found in pHJW20, pJS01, pJS02, pDH01, pJS03, pHJW34, 
pHJW35 and pHJW36, respectively. (B) Solid black arrows represent the relative position and 
orientation of the nine putative VirB binding sites identified within the promoter fragments used in 
this work.  In each case, the match to the consensus sequence 5’-(A/G)(A/T)G(G)AAAT-3’ (Tobe et 
al., 1993, Watanabe et al., 1990) is given. 
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sequences would also influence the activity of the other promoter fragments.  
Furthermore, the increase in promoter activity was unlikely to be caused by the creation 
of a new VirB binding site at the boundary of the plasmid backbone and the promoter 
region, because two additional constructs with altered plasmid-promoter boundaries 
(pMIC01 and pMIC02 [Table 1]) were found to have similar activities to those displayed 
by pHJW20.  
The simplest interpretation of these data was that DNA sequences located between 
positions 1232 and 1056 upstream of the icsP transcription start site are required for 
VirB dependent regulation of the icsP promoter.  
 
 
Fig. 12.  Activities of the truncated icsP promoter series in Shigella.  Bars indicate β-
galactosidase expression of the PicsP-lacZ fusions in wild-type S. flexneri (2457T) and an isogenic 
strain lacking virB (AWY3). β-galactosidase activities are expressed in Miller units. Assays were 
run in triplicate and the mean and standard deviations are shown. 
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Identification and site-directed mutagenesis of putative VirB binding sites 
responsible for VirB-dependent regulation of the icsP promoter.  
 Previous analysis of the icsB, spa15 and virA promoters of Shigella sonnei 
established a consensus binding site for VirB (Taniya et al, 2003).  Our analysis of 
sequences upstream of the icsP gene identified nine sites with greater than a 6/7 match 
to the consensus, 5’-(A/G)(A/T)G(G)AAAT-3’ (Fig. 12B; Turner & Dorman, 2007).  
Three of these sites are located between -665 to -351. The location of these sites may 
explain why small and yet significant increases in VirB dependent promoter activity 
were observed in wild-type Shigella flexneri carrying promoter constructs with upstream 
boundaries of -665, -883 and -1056 relative to the icsP transcription start site (+1) (Fig. 
11).  Two other putative VirB binding sites are located immediately downstream of the 
transcription start site.  Although the location of these sites may explain the small 
increase in VirB dependent promoter activity associated with the shortest promoter 
fragment used in our studies, our data suggest that these sites alone play no significant 
role in the presence of upstream promoter sequences. 
 Interestingly, two of the nine sites identified upstream of the icsP gene are located 
between positions -1144 and -1130 and are organized as an inverted repeat (Fig. 11B). 
Since our truncation analysis indicates that sequences between -1232 and -1063 are 
essential for a 17-fold increase in promoter activity in the presence of VirB (Fig. 12), we 
chose to analyze these sites further.  Seven base pair substitutions were made in either,  
 the upstream site (box 2), the downstream site (box 1) or both, using a PCR site-
directed mutagenesis method described by Lie & Leigh (2007) (Appendix 1; Table 1).   
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Each mutated promoter fragment was then introduced into the lacZ reporter plasmid 
pHJW20 to replace the existing wild-type sites the resulting plasmids pMIC13, pMIC17, 
pMIC18, and pHJW20 and a promoterless control, pMIC21 (Table 1) were introduced 
into wild-type Shigella (2457T) and the virB mutant (AWY3) and β-galactosidase levels 
were measured (Table 1). 
 Our data revealed that complete mutagenesis of the upstream binding site (box 2), the 
downstream binding site (box 1) or both, resulted in complete loss of VirB dependent 
regulation of the icsP promoter.  Further more, these results were not an artifact of the 
lacZ reporter constructs, because similar patterns of expression were observed when the 
icsP gene was fused to each of our promoter constructs and IcsP levels were measured 
by Western blotting (data not shown).  These data strongly suggest that VirB regulates 
the icsP promoter from sequences located more than 1 kb upstream of the icsP 
Table 1. Summary of mutations introduced into the two boxes that form the upstream 
inverted repeat and activities of wild-type and mutated icsP promoter fragments 
Fragment description Sequencea β-galactosidase activity b  
  virB+ virB mutant 
 
     WT Box 1 & 2 
 
 
 CGGGGATTTCAGTATGAAATGAAGTA 
 
4291 ± 453 
 
397 ± 12 
     Mutated Box 1 
  CGGGGATTTCAGTCGACCCGGAAGTA 
345 ± 46 378 ± 29 
     Mutated Box 2 
  CGGGGGCCCAGCTATGAAATGAAGTA 
370 ± 65 359 ± 29 
     Mutated Box 1 & 2 
  CGGGGGCCCAGCTCGACCCGGAAGTA 
360 ± 57 371 ± 26 
     Promoterless lacZ  346 ± 70 415 ± 33 
a 5’-3’ DNA sequences of the wild-type and mutated boxes that form the upstream inverted repeat. 
Sequences lie between -1144 and -1130 relative to the annotated tss of icsP (+1;(Egile et al., 1997)). 
Bases in bold indicate those mutated by site-directed mutagenesis.  
b All promoter fragments were fused to lacZ and β-galactosidase activities were measured in wild-type S. 
flexneri (2457T) and the isogenic strain that lacks virB (AWY3).  The parent cloning vector with a 
promoterless lacZ gene was included as a negative control.  β-galactosidase activities are expressed in 
Miller units. Assays were run in triplicate and the mean and standard deviations are shown. 
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transcription start site. To our knowledge, this is the first evidence that VirB can 
influence promoter activity from such distal sites.  
Conserved sequence and location of the two distal VirB binding sites in all known 
Shigella sequences and in EIEC strain HN280.   
 To examine how well conserved DNA sequences located upstream of the icsP 
promoter are among other Shigella strains, species and other enterics, a 2 kb sequence 
upstream of the icsP gene in Shigella flexneri 2457T was subjected to BLAST analysis. 
All known Shigella virulence plasmid sequences and the virulence plasmid of the 
enteroinvasive Escherichia coli (EIEC) strain HN280 contain nearly identical sequences 
(99-100% identity) over the entire 2 kb sequence upstream of the icsP gene.  
Furthermore, the upstream inverted repeat identified by our studies was 100% identical in 
all strains and located in exactly the same position relative to the annotated transcription 
start site identified in S. flexneri.  These findings strongly suggest that icsP genes found 
in all Shigella spp. and the EIEC strain HN280 are likely to be regulated by VirB from a 
biding site located more than 1 kb upstream of the gene. 
VirB is structurally homologous to plasmid partitioning proteins, which can 
influence transcription from distances of several kilobases. 
While it is unusual for transcription factors to influence transcription from 
distances greater than 200 bp upstream or downstream of the transcription start site in 
bacteria (Balleza et al., 2009, Collado-Vides et al, 1991), some examples exist.  For 
example, the enhancer of the Bacillus subtilis rocG gene is located 1.5 kb downstream 
of the promoter and, beyond the end of the rocG coding region (Belitsky et al., 1999) 
and the two NtrC binding sites required for transcriptional activation of E. coli σ54-
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regulated glnA promoter can still function when placed as far as 3 kb from the promoter 
(Reitzer & Magasanik, 1986).  Furthermore, bacterial plasmid partitioning factors, while 
not typically considered transcription factors, have also been shown to silence the 
promoters of genes in the vicinity of their cis-acting binding sites from over distances of 
several kilobase pairs (Kim & Wang, 1999, Rine, 1999, Rodionov et al, 1999, Rodionov 
& Yarmolinsky, 2004).  One of these proteins, the P1 ParB protein, displays structural 
homology to VirB and has bridging capabilities: the ability to interact with other ParB 
monomers located at binding sites further up or downstream. It is therefore possible that 
the other seven sites with close matches to the VirB consensus binding site play an 
important role in bridging by VirB and the resulting DNA topology is central to the 
alleviation of H-NS dependent repression of the icsP promoter, although this needs to be 
tested. 
In summary, although transcription factors typically bind to sequences located 
within 200 bp upstream or downstream of the transcription start site (Balleza et al, 2009, 
Collado-Vides et al, 1991), here we provide strong evidence that VirB has the capacity 
to alleviate H-NS dependent repression of the icsP promoter from sites located over 1 kb 
upstream of the transcription start site.  This raises two important questions.  (i) Are 
other Shigella virulence plasmid genes regulated from remote VirB binding sites?  (ii) Is 
it common for transcriptional anti-silencing mechanisms to employ distal regulator 
binding sites?  Future studies will address these questions and elucidate the molecular 
mechanism of H-NS dependent repression and VirB dependent de-repression of the icsP 
promoter.  
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CHAPTER 3 
TRANSCRIPTIONAL SILENCING AND ANTI-SILENCING OF THE ICSP 
PROMOTER OF SHIGELLA FLEXNERI: REMOTE REGULATION  
BY H-NS AND VIRB 
Abstract 
 In the bacterial pathogen Shigella flexneri, many genes encoded by the large 
virulence plasmid are repressed by the nucleoid structuring protein H-NS and de-
repressed by the major virulence gene activator VirB.  One example is the icsP gene, 
which encodes an outer membrane protease.   In this study, we demonstrate that 
sequences located over 665 bp upstream of the annotated transcription start site (+1) are 
needed for complete H-NS-mediated repression of the icsP promoter.  Using 
electrophoretic mobility shift assays (EMSAs), we show that H-NS binds directly to 
DNA sequences located both upstream of -665 and downstream of -213 and that both of 
these regions contain sequences predicted to display high levels of intrinsic curvature.  
These data support a model where H-NS docked at remote sites may act in concert with 
H-NS docked at promoter proximal sequences to mediate H-NS-dependent repression of 
the icsP promoter. While we again demonstrate that VirB functions solely to de-repress 
the promoter, our EMSA data indicate that VirB and H-NS are capable of binding 
simultaneously to the full intergenic region (1232 bp) that lies immediately upstream of 
the icsP gene.  This suggests that VirB may function to relocate H-NS, rather than 
causing H-NS to dissociate from the DNA upstream of the icsP gene. Our findings 
contribute to our understanding of transcriptional silencing and anti-silencing 
mechanisms that control virulence gene expression in Shigella and other enteric 
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pathogens and raise the possibility that other bacterial promoters may be regulated from 
remote transcription factor binding sites. 
 Authors: Dustin J. Harrison, Karen M. Levy, Amber J. Howerton, Christopher T. 
Hensley and Helen J. Wing 
 We thank Dr. Eric Anderson and Dr. Martin Roop from East Carolina University for 
all their help and guidance with the EMSAs, Stephanie Labahn for technical support and 
Drs. Eduardo Robleto, Dennis Bazylinski and Patricia Cruz for critical reading of the 
manuscript. 
3.1 Introduction 
Shigella species are gram-negative intracellular pathogens that cause bacillary 
dysentery in humans.  Shigella infections are responsible for approximately 164 million 
infections each year resulting in 1.1 million deaths, most of these occur in developing 
countries and in children less than 5 years old (Kotloff et al., 1999, Lee et al., 2005, Li et 
al., 2009).  All four Shigella species carry a large (230 kbp) virulence plasmid. Many 
genes encoded by these plasmids are under the transcriptional control of the histone-like 
nucleoid structuring protein (H-NS) and the major virulence gene activator VirB (Adler 
et al., 1989, Berlutti et al., 1998). 
 H-NS is a nucleoid structuring protein that is well characterized as a silencer of 
bacterial transcription (Ali Azam et al., 1999, Dorman, 2004).  In enteric pathogens, H-
NS silences the transcription of many virulence genes, which have been acquired by 
horizontal gene transfer (Dorman, 2009a).  Silencing of newly acquired genes by H-NS is 
thought to protect the bacterium from potentially deleterious effects of transcribing genes 
that may compromise their fitness (Navarre et al., 2006) until they can be integrated into 
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existing regulatory networks (Navarre et al., 2007, Dorman, 2009b).  Among the enterics, 
horizontally acquired genes are frequently AT rich. Such sequences typically display high 
levels of intrinsic curvature. Previous investigations indicated that H-NS is a direct, non-
specific DNA binding protein with an affinity for DNA with high intrinsic curvature 
(Spassky et al., 1984, Zhang et al., 1996, Zuber et al., 1994, Williams et al., 1996, 
Williams & Rimsky, 1997, Yamada et al., 1991, Zuber et al., 1994) which may explain, 
at least in part, why H-NS is the protein of choice for transcriptional silencing in these 
bacteria. More recent work at the E. coli proU promoter (Lang et al., 2007) has led to the 
description of a high affinity H-NS binding site, however it remains unclear whether this 
sequence is found in all H-NS regulated promoters, or whether other sequences can 
contribute to H-NS binding. Regardless, DNase I protection assays have demonstrated 
that H-NS oligomerizes along AT rich sections of bacterial promoters (Rimsky et al., 
2001, Turner & Dorman, 2007). This can lead to the formation of H-NS-DNA-H-NS 
bridges, which have been visualized using atomic force microscopy as looped DNA 
structures constrained by H-NS (Maurer et al., 2009).  These structures may involve long 
stretches of DNA, extending over 1 kb (Dame et al., 2000, Dame et al., 2005, Dame et 
al., 2006, Maurer et al., 2009), and have been documented as playing important roles in 
promoter silencing (Bouffartigues et al., 2007, De la Cruz et al., 2009, Dorman, 2004, 
Dorman, 2009a, Fang & Rimsky, 2008, Navarre et al., 2006, Stoebel et al., 2008). 
Disruption of these H-NS:DNA complexes by other DNA-binding proteins can allow 
transcriptional de-repression; a process coined anti-silencing (Fang & Rimsky, 2008, 
Navarre et al., 2007, Stoebel et al., 2008).  
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 The virulence gene activator VirB is encoded by the Shigella virulence plasmid and 
its expression is regulated by another transcription factor VirF (Adler et al., 1989).  At 
the non-permissive temperature of 30 ˚C many genes encoded by the virulence plasmid 
are repressed by H-NS (Beloin & Dorman, 2003, Hromockyj et al., 1992, Porter & 
Dorman, 1994).  Upon a switch to 37 °C, H-NS dissociates from the virF promoter 
leading to the production of the virulence gene regulator, VirF (Adler et al., 1989).  VirF 
relieves H-NS-dependent repression of the virB promoter (Tobe et al., 1993, Watanabe et 
al., 1990) and subsequently VirB alleviates H-NS dependent repression of many 
virulence plasmid genes, including virA, icsP, ospB, phoN2 and those encoding the type 
III secretion system that mediate host cell invasion; ipa, mxi and spa (Beloin & Dorman, 
2003, Berlutti et al., 1998, Dorman, 2006, Hromockyj et al., 1992, Maurelli et al., 1984a, 
Maurelli et al., 1984b, Nicoletti et al., 2008, Porter & Dorman, 1994, Porter et al., 1998, 
Prosseda et al., 1998, Sasakawa et al., 1993, Tobe et al., 1991, Tobe et al., 1993, Tobe et 
al., 1995).  Consequently, transcriptional de-repression of virulence genes by VirF and 
VirB is central to the pathogenicity of Shigella. Since VirF and VirB both function to 
antagonize H-NS mediated repression of virulence genes, both proteins can be considered 
transcriptional anti-silencing proteins.   
 The mechanism underlying transcriptional silencing/anti-silencing has been proposed 
to be a straightforward molecular antagonism involving competition between the 
silencing protein and the anti-silencing protein for their overlapping cognate DNA 
binding sequences, which are usually located in the immediate vicinity of the promoter. 
Typically this competition results in the dissociation of the silencing molecule from the 
DNA (Fang & Rimsky, 2008, Navarre et al., 2007). Examples of this kind of 
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straightforward transcriptional silencing/anti-silencing exist at a variety of bacterial 
promoters, e.g. SlyA counters H-NS silencing of the hemolysin gene hlyE in E. coli 
through direct competition for the DNA, RovA from Yersinia counters silencing of the 
invasin inv, and the urease gene activator UreR of Proteus mirabilis causes H-NS to 
dissociate from DNA located between the divergently transcribed ureR and ureD genes 
(Coker et al., 2000, Ellison & Miller, 2006a, Ellison & Miller, 2006b, Heroven et al., 
2004, Heroven et al., 2007, Lithgow et al., 2007, Poore & Mobley, 2003).  In contrast, at 
some bacterial promoters the anti-silencing proteins function to alter the DNA topology 
in a way that no longer allows H-NS to constrain transcription.  For example, LeuO 
counters silencing of the quiescent porin ompS1 in Salmonella by altering the topology of 
the ompS1 promoter region (De la Cruz et al., 2007, De la Cruz et al., 2009) and in 
Shigella flexneri, VirB antagonizes H-NS by affecting the structure of the icsB promoter 
(Turner & Dorman, 2007).  
 Our previous work shows that the horizontally acquired, monocistronic icsP gene, 
located on the Shigella virulence plasmid, is repressed by H-NS and de-repressed by 
VirB. We have demonstrated that the role of VirB is to solely alleviate transcriptional 
repression of the icsP promoter, which is mediated by H-NS (Castellanos et al, 2009, 
Wing et al., 2004).  Surprisingly, two putative VirB binding sites, organized as an 
inverted repeat and located over 1 kb upstream of the annotated transcription start site are 
indispensible for the de-repression of the promoter (Castellanos et al., 2009).  These sites 
lie in a designated 1.2 kb intergenic region (Jin et al, 2002); Reference Sequence: 
NC_004851.1). Currently, it remains unclear which DNA sequences are required for the 
H-NS dependent repression of icsP.  Furthermore, although our previous work strongly 
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suggests VirB binds directly to this upstream intergenic region, this has never been 
categorically demonstrated.   
 In this study, we further examine the role that H-NS and VirB play in the regulation 
of the icsP promoter in an attempt to discern the molecular mechanism responsible.  Our 
results suggest that both H-NS and VirB regulate the activity of the icsP promoter from 
remotely located sequences. We propose a model to explain how silencing and anti-
silencing of the icsP promoter is achieved by DNA binding-proteins binding to remote 
sequence elements. We envisage that an improved understanding of H-NS and VirB 
dependent regulation of the icsP promoter will provide insight into bacterial regulation of 
transcription from remote sites.   
3.2 Materials and Methods 
Bacterial strains and plasmids.   
 The bacterial strains and plasmids used in the present study are given in Appendix 1.  
Bacteria were grown routinely at 37 °C in Luria-Bertani broth, with aeration, or on LB 
agar (LB broth containing 1.5 % [wt/vol] agar). Antibiotics were added at the following 
final concentrations: ampicillin, 100 µg ml-1; chloramphenicol, 25 µg ml-1; kanamycin, 
50 µg ml-1; and tetracycline, 12.5 µg ml-1. 
Construction of the PicsP-lacZ reporter plasmid and truncated promoter fragments.  
 The PicsP-lacZ reporter plasmid pHJW20 was used as the basis for this work 
(Castellanos et al., 2009, Wing et al., 2004); Table 1).  pHJW20 carries 1232 bp 
upstream of the annotated transcription start site of the icsP promoter, the first 48 bp of 
the icsP coding region cloned upstream of a translation stop site, and a promoterless lacZ 
gene, so that expression of lacZ is directly regulated by the icsP promoter. Promoter 
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fragments of 1056 bp, 893 bp, 665 bp, 351 bp, 254 bp, 150 bp, and 92 bp, were PCR 
amplified and cloned into pHJW20 to replace the 1232 bp icsP promoter (Castellanos et 
al., 2009).  This created a nested set of PicsP-lacZ fusion plasmids that could be used to 
identify regions of the icsP promoter needed for H-NS and VirB-dependent regulation. 
All cloned promoters have been sequenced and are identical to the sequence reported for 
pCP301 (S. flexneri serotype 2a: NCBI Reference Sequence: NC_004851.1). All 
plasmids are described in Appendix 1.   
Quantification of icsP promoter activity using the PicsP-lacZ reporter and 
derivatives.  
 Activity of the icsP promoter was determined by measuring β-galactosidase activity 
as described previously (Wing et al., 2004) using the Miller protocol (Miller, 1972), in 
strains carrying pHJW20 or derivatives. Freshly transformed cells were back-diluted 
1:100 in LB and grown at 37 °C for 4 to 5 h to early stationary phase prior to cell lysis, 
because icsP expression is maximal under these conditions (Wing et al., 2004).  When 
appropriate, to examine the effect of expressing virB from the pBAD vectors, cells were 
instead back-diluted 1:100 in 5 ml of LB medium containing 0.2% (wt/vol) glucose and, 
after 4 to 5 h were harvested, washed with an equivalent volume of LB medium and 
diluted 5-fold into LB medium containing either 0.08% (wt/vol) L-arabinose.  Cultures 
were then grown for an additional 2 h before being harvested. All assays were performed 
in triplicate on three separate occasions.   
In silico analyses of the icsP promoter and upstream sequences.   
 The MUTACURVE server (http://132.248.32.45/cgi-bin/mutacurv.cgi) was used to 
predict regions of intrinsic DNA curvature.  This program evaluates the amplitude of 
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intrinsic curvature for every nucleotide in a given sequence using the algorithm of 
Goodsell & Dickerson (1994), with the addition of Satchwell’s contribution matrices for 
rotational and spatial displacements (Satchwell et al., 1986).  These algorithms have been 
routinely used by other investigators to identify putative HNS binding sites in DNA 
(Beloin & Dorman, 2003, De la Cruz et al., 2009, Flores-Valdez et al, 2003,Will & Frost, 
2006). 
Construction of inducible plasmids and purification of the VirB and H-NS proteins.  
 The virB gene was digested from pATM324 using HindIII and NcoI restriction 
enzymes and gel purified.  The primers W38 and W39 were used to amplify the virB 
gene which was then ligated into pQE-60 (Qiagen) before electroporation into E. coli 
M15 pREP4 creating a C-terminal His-tagged VirB in an inducible plasmid, pAJH01.  A 
similar strategy was used to create a C-terminal His-tagged H-NS in an inducible 
plasmid, pCTH01.  Briefly, the primers W134 and W137 (Appendix 1) were used to 
amplify the hns gene from Shigella flexneri serotype 2a with NcoI and BglII sites for 
cloning into pQE-60.   
 His-tagged-VirB and His-tagged-H-NS proteins were overproduced from plasmid 
pAJH01, and pCTH01 respectively.  Proteins were expressed in the E. coli strain M15 
carrying the plasmid pREP4.  The expression of the C-terminally His-tagged proteins 
were induced in 500 ml cultures growing exponentially with 1mM IPTG (isopropyl-β-
thiogalactopyranoside). Two hours post-induction, the cells were harvested and frozen at 
80 °C overnight.  The cell pellet was thawed on ice and resuspended in lysis buffer (40 
mM Tris-base [pH 8.93], and 80 mM NaCl). Cells were lysed by sonication, and cellular 
debris was pelleted by centrifugation at 10 000 x g at 4 °C.  Cell lysates were applied to 
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Ni-NTA columns (Qiagen) pre-equilibrated with equilibration buffer (40 mM Tris-base 
[pH 8.93], 80 mM NaCl, 10 mM imidazole).  The columns were then washed with 10 bed 
volumes of wash buffer (equilibration buffer with 20 mM imidazole) prior to elution of 
the proteins by the addition of 2.5 bed volume of elution buffer (equilibration buffer with 
250 mM imidazole).  Eluates were analyzed by SDS-PAGE followed by Coomassie 
staining. Purified proteins were dialyzed in equilibration buffer overnight at room 
temperature. Protein concentrations were determined using Bradford Assays.  The hexa-
his tag was not found interfere with VirB expression or activity, because His-tagged VirB 
was observed to restore IcsP expression to wild type levels in a strain lacking virB in vivo 
(data not shown). Furthermore, previous studies using an identical His-tag H-NS fusion 
protein, produced in a manner similar to that described above, was shown to retain 
normal function of H-NS in assays (Williams & Rimsky, 1997).  
Electrophoretic Mobility Shift Assays (EMSAs).   
 The upstream intergenic region of the icsP promoter (1232 bp) was used as a template 
to amplify six, overlapping smaller fragments, ranging from 252 bp to 358 bp by PCR 
(Appendix 1).  A positive control promoter fragment, icsB, was amplified by PCR using 
the Shigella flexneri virulence plasmid as a template, a negative control fragment, pstS, 
was amplified from the E. coli genome (Appendix 1) and a non-specific competitor, a 
147 bp fragment of DNA from pACYC184 was amplified from pACYC184 by PCR. The 
full-length upstream intergenic region of the icsP promoter (icsP’) was also used in 
EMSA (generated using primers W63 and W149), as well as a 1011 bp negative control 
fragment of the E. coli pstS gene (pstS’) (Appendix 1). 100 nM of each DNA fragment 
was incubated with increasing concentrations of purified protein, VirB, H-NS, or both (0 
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to 920 nM) for 30 minutes at 30 °C for both VirB and H-NS, in a 20 µl reaction mixture 
containing 40 mM Tris-base (pH 8.93), 80 mM NaCl, 1 mM EDTA, 1 mM DTT, 
200 ng ml-1 bovine serum albumin (BSA), 200 nM of competitor p184 DNA and 10 % 
glycerol.  DNA concentrations were measured using the NanoView (GE).  The protein-
DNA complexes were resolved by electrophoresis in 1.5 % TBE agarose gels for 4 h at 
room temperature at 60 V constant.  Following electrophoresis, the agarose gels were 
stained with ethidium bromide (1 µg ml-1) and visualized using a Typhoon 9410 
(Amersham) variable mode imager.  EMSAs were performed a minimum of three times 
and representative results are shown. 
3.3 Results 
Identification of regions necessary for the H-NS dependent repression of the icsP 
promoter 
 Although we have demonstrated that DNA sequences located over 1 kb upstream of 
the annotated icsP transcription start site are required for VirB-dependent de-repression 
Fig. 13.  Schematic of the 1.2 kb region located upstream of the icsP gene. Relative positions and 
orientation of putative VirB-binding sites are shown (Castellanos et al., 2009). Fragments of 
different lengths represents regions DNA cloned upstream of our lacZ reporter in our truncation 
series.  Coordinates are given in bp and relative to the annotated transcription start site 
(characterized by Egile et al., 1997). 
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of the icsP promoter (Castellanos et al., 2009), little is known about the sequences 
required for H-NS-dependent repression of the icsP promoter.  To identify regions of the 
icsP promoter required for H-NS-dependent repression we used a nested set of PicsP-
lacZ fusion plasmids (constructed previously in Castellanos et al., 2009).  The promoters 
contained within this PicsP-lacZ fusion series share the same downstream boundary, but 
their upstream boundaries differ, ranging from -1232 to -351 with respect to the 
annotated transcription start site (+1) (Egile et al., 1997) (Fig.13). 
 Each reporter plasmid was transformed into the E. coli strain MC4100 and an 
isogenic strain lacking hns (MC4100 hns).  These strains were used to avoid interference 
arising from the fact that in Shigella virB is directly regulated by H-NS and the fact that 
Shigella hns mutants are notoriously unstable (Maurelli, personal comm.).  A similar 
strategy has been used by others to study the regulation of other Shigella promoters by H-
NS (Beloin & Dorman, 2003).  A plasmid carrying an inducible copy of the virB gene 
was next introduced into each of the E. coli strains (neither strain expresses virB 
naturally) so that the effect of H-NS on the icsP promoter could be measured in the 
presence and absence of VirB.   
 The results of the β-galactosidase assay are shown in Fig. 14.   In the wild type 
background, the four longest promoter fragments had significantly lower activity than in 
the hns mutant. These data suggest sequences upstream of -351 are sufficient for H-NS-
dependent repression, although sequences upstream of -665 are required for full 
repression. Induction of VirB in the wild-type background increased the activity of the 
longest promoter by 10 fold.  This is consistent with data obtained in a Shigella 
background (Castellanos et al., 2009) and demonstrates that VirB alleviates H-NS 
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dependent repression of the icsP promoter when sequences located over 1 kb upstream of 
the annotated transcription start site are present. In the hns mutant background, all 
constructs displayed activity higher than 1000 units, regardless of the whether virB was 
induced or not. This indicates that H-NS mediates repression of the four longest 
constructs in our promoter series and that VirB functions solely to relieve H-NS 
dependent repression at the longest construct. Similar observations were made in 
previous studies (Wing et al., 2004, Castellanos et al., 2009). 
 
 Surprisingly, induction of VirB in the wild type background has a repressive effect on 
the activity of the two shortest promoter constructs examined, -665 bp and -351 bp. It is 
not clear whether VirB mediates this effect directly, although putative VirB binding sites 
have been identified within these fragments (Fig. 4; Castellanos et al., 2009).  
Fig. 14.  Activities of the truncated icsP promoter fragments in the presence and absence of H-NS 
and /or VirB.  Constructs are labeled according to the upstream boundary from the transcription start 
site.  Bars indicate β-galactosidase expression of the PicsP-lacZ fusions in wild type E. coli MC4100 and 
an isogenic strain lacking hns (MC4100 hns::Knr) under inducing and non-inducing conditions for virB 
which is included on an inducible plasmid.  β -galactosidase activities are expressed in Miller units.  
Assays were run in triplicate and error bars represent the mean and standard deviations. 
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Furthermore, in the context of the shortest promoter construct (-351), the typical role of 
H-NS and VirB is reversed; VirB still functions to antagonize H-NS, but now functions 
to alleviate H-NS-dependent activation. These data demonstrate that H-NS and VirB are 
true molecular antagonists, which, under the right circumstances, can reverse their roles. 
This finding provides valuable insight into the molecular mechanisms of transcriptional 
silencing and anti-silencing in bacteria.  In vitro transcription assays will be performed to 
test the hypothesis that H-NS increases the activity of the short promoter constructs.  
 Taken together, these data demonstrate that sequences located upstream of -351 are 
needed for H-NS-dependent repression of the icsP promoter. In the absence of these 
upstream sequences, sequences downstream of 351 permit the H-NS-dependent 
activation of the icsP promoter. Although H-NS-dependent repression and activation of 
these truncated icsP promoter fragments is likely mediated by H-NS binding directly to 
DNA sequences located upstream of -351 and downstream of -351, respectively, this 
needed testing. 
H-NS binds to two 
discrete regions upstream 
of the icsP gene 
 In order to determine 
whether H-NS binds to 
DNA located upstream of 
the icsP gene, 
electrophoretic mobility 
shift assays (EMSAs) were 
Fig. 15.  Schematic showing the 6 target fragments used in the 
EMSAs.  Coordinates of each target fragment are given relative 
to the transcription start site.  Inverted triangles denote the 
position of a peak of high intrinsic curvature predicted using the 
MUTACURVE program. 
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used. The full intergenic region that lies upstream of the icsP gene (1232 bp) was divided 
up into six near equal length fragments and each of these fragments were used in EMSAs 
with purified His-tagged H-NS (Fig. 15).  
For these experiments, a DNA fragment containing sequences that lie between the 
divergent icsB and ipgD genes of Shigella flexneri was used as a positive control (icsB), 
because H-NS has been shown to bind to this promoter region by others (Turner & 
Dorman, 2007) and an internal fragment of the E .coli pstS gene was used as a negative 
control (pstS). Each DNA fragment was incubated with increasing concentrations of 
purified His-tagged H-NS in the presence of a 147 bp fragment, which had been 
amplified from the plasmid pACYC184 and which served as non-specific competitor 
DNA (200 nM). DNA and DNA:protein complexes were then resolved by agarose gel 
electrophoresis.   
Fig. 16.  H-NS binding to discrete regions within the icsP upstream intergenic region.  EMSAs were 
conducted using 100 nM of each fragment shown in Fig. 3 and increasing concentrations of purified His-
tagged H-NS.  The concentrations of purified protein as well as the target fragment used are given above 
each lane.  In all cases, the lower band is 200 nM of competitor DNA generated from pACYC184.  
Positive control, and negative controls are labeled icsB and  pstS respectively. 0=no protein, 1=120 nM, 
2=230 nM, 3=460 nM,4=920 nM protein.  
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Based on previous in vitro studies with H-NS and H-NS-regulated promoters, and due to 
the ability of H-NS to oligomerize along DNA, EMSAs performed with H-NS often do 
not appear as discrete shifted bands, but are more diffuse (Azam & Ishihama, 1999, 
Doyle et al., 2007).  Despite this, we fully expected that some of the six DNA fragments 
would harbor regions that would interact with H-NS at lower concentrations than others. 
Our results show that H-NS binds to target fragments, T6, T5, T4, T3 and T1, with T5 
and T4 shifting at the lowest concentration of protein, 120 nM (Fig. 16).  The shift of T1 
is apparent after incubation with 230 nM of protein while T6 and T3 only shift after 
incubation with H-NS concentrations of 460 nM.  In contrast, T2 fails to shift in the 
presence of H-NS even at high concentrations of H-NS protein (920 nM).  In each case, 
H-NS binding to the icsP promoter is specific as evidenced by the uniform presence of 
free non-specific competitor DNA in all lanes.   
 The DNA fragments that shift with the lowest concentration of H-NS protein, T5 and 
T4, contain sequences located between -1058 to -523 relative to the transcription start 
site. This region is present in all constructs that displayed full H-NS-dependent repression 
of the icsP promoter in our previous in vivo experiments (Fig 15; promoters with 
upstream boundaries of -1056, -893, and -665 all contain sequences contained within 
target T5 and T4).  These data support our hypothesis that H-NS directly binds to the icsP 
upstream intergenic region to mediate H-NS dependent repression. Furthermore, T1 also 
shifted with relatively low concentration of H-NS. This fragment contains sequences 
located between 213 and +24 relative to the transcription start site. The binding of H-NS 
to this region of DNA may explain the H-NS-dependent increase in icsP promoter 
activity observed at the shortest promoter construct in our in vivo assays, although this 
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still needs to be tested.  Also, future studies using DNase I footprint analyses, described 
in Chapter 4, will enhance our understanding of the nature of H-NS binding to these 
DNA target sequences.   
Regions bound by H-NS are predicted to display high levels of intrinsic curvature 
 H-NS is well documented to bind preferentially to DNA that displays high intrinsic 
curvature (Dame et al., 2000, Dorman, 2006, Rimsky et al., 2001). To determine whether 
regions lying upstream of the icsP gene are likely to be intrinsically curved, in silico 
analysis of the icsP promoter was performed using the MUTACURVE program.  Based 
on these analyses, five regions were found to display curvature values ≥7°/helical turn. 
Since experimentally tested curved motifs produce curvature values of 5–25°/helical turn, 
whereas straight motifs give values below 5°/helical turn, our findings are consistent with 
these five regions being curved and potentially binding H-NS.  
 Four of the regions predicted to be intrinsically curved lie upstream of -351 (at 
positions -935, -842, -663, -435; data not shown; inverted triangles Fig. 15).  In our in 
vivo assays this DNA was required for the H-NS dependent repression of the icsP 
promoter (Fig. 15).  Furthermore, H-NS bound specifically to this DNA in our EMSAs 
(Fig. 16).  A fifth region of predicted curvature was found to lie around the transcription 
start site itself.  This may explain why H-NS interacts directly with target 1 in our 
EMSAs (Fig. 16) and why this region mediates H-NS dependent activation of the icsP 
promoter in our β-galactosidase assays (Fig 14).  
 The finding that H-NS binds specifically to regions upstream of the icsP gene that are 
predicted to be intrinsically curved is consistent with the previously reports that H-NS 
display affinity for DNA sequences with high intrinsic curvature (Azam & Ishihama, 
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1999, Badaut et al, 2002, Beloin & Dorman, 2003, Berlutti et al., 1998, Bloch et al., 
2003, Bouffartigues et al., 2007, Corcoran & Dorman, 2009, Dorman & Kane, 2009, 
Noom et al, 2007, Dame et al., 2000, Dame et al., 2005, Dame et al., 2006, De la Cruz et 
al., 2007, De la Cruz et al., 2009, Rimsky et al., 2001, Rimsky, 2004, Turner & Dorman, 
2007). Although, more recent work at the proU promoter of E. coli has identified a 10 bp 
sequence which binds H-NS with high-affinity (Lang et al., 2007), a rudimentary search 
for such a sequence, within the upstream intergenic region of icsP to 100 bp downstream 
of the tss, yielded no good matches.   
 Preliminary experiments designed to test the curvature of these 5 regions, by 
electrophoresis in acrylamide gels at room temperature and 4 °C (curved DNA displays 
anomalous migration at 4 °C), suggest that these regions are indeed curved (k values all 
greater than 1 [k value = ratio of the apparent size of a DNA fragment/ true size of a 
DNA fragment; k ≥1 = curved DNA]), however, this needs repeated (data not shown; De 
la Cruz et al., 2009, Prosseda et al., 2004). 
VirB binds to the intergenic region that lies upstream of the icsP gene  
 Our previous studies revealed that sequences located 1 kb away from the annotated 
transcription start site are absolutely required for the VirB dependent regulation of icsP 
activity (Castellanos et al., 2009). It remains unclear, however whether VirB binds 
directly to the icsP promoter or mediates is effect indirectly through another VirB-
regulated protein.  To test this, EMSAs using purified His-tagged VirB protein were used.  
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 The full upstream intergenic region of the icsP promoter (icsP’; 1232 bp) was 
incubated with increasing concentrations of purified His-tagged VirB.  Again, an internal 
fragment of the E. coli pstS gene was used as a negative control for these experiments, 
but a longer fragment (1011 bp) was used to mirror the increased length of the fragment 
of interest.  As previously described, a 147 bp fragment amplified from the plasmid 
pACYC184 (p184; 200 nM) was included in each reaction as a non-specific competitor 
DNA and DNA:protein complexes were resolved by agarose gel electrophoresis.  
 Our data show that a DNA fragment amplified from the entire intergenic region (1232 
bp) located upstream of the icsP gene, was retarded by 230 nM of VirB, with complete 
retardation after incubation with 460 nM of VirB (Fig. 17a).  The binding of VirB to this 
DNA was specific at concentrations between 230-460 nM, because VirB does not bind to 
the non-specific competitor DNA p184 nor the negative control fragment pstS’ at these 
Fig. 17. VirB and H-NS binding of the full length icsP upstream intergenic region.  EMSA results of 
the long, >1 kb, DNA fragments.  a) shows the shift the full length icsP upstream intergenic region 
(icsP’), compared to the negative control, the 1011 bp fragment of the E. coli pstS (pstS’),  b) shows H-
NS the shift of the full length icsP upstream intergenic region (icsP’), compared to the negative control.  
The concentrations (nM) of purified protein are given above each lane with the identity of the target given 
below.  In all cases the lower band represents 200 nM of non-specific competitor DNA derived from 
pACYC184. 
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concentrations. Some non-specific binding to the pstS’ fragment was observed at VirB 
concentrations above 460 nM, however.   
 Although the VirB-dependent shift of the upstream intergenic region appears as a 
smear in these EMSAs, this appears to be a characteristic of VirB:DNA interaction in 
vitro, because Turner & Dorman (2007) reported similar observations when studying 
VirB:DNA  interactions with the Shigella icsB promoter by EMSAs.  Furthermore, 
although the magnitude of the shift is not as dramatic as commonly seen in EMSAs using 
DNA fragment of approximately 100-300 bp, it should be remembered that the DNA 
probe in these experiments much larger.  It is likely that this accounts for the moderate 
shift observed.  Regardless, there is a specific loss of free icsP’ probe DNA with 
increasing concentrations of protein.  We therefore conclude that VirB binds directly to 
the 1.2 kb region that lies immediately upstream of the icsP promoter, and this binding is 
likely required for the VirB-dependent regulation of the icsP promoter.   
H-NS does not bind to discrete regions upstream of the icsP gene cooperatively  
 Both our in vivo and in vitro data strongly suggests that H-NS binds to two discrete 
regions upstream of the icsP gene (upstream of -351 and downstream of -213). We next 
wanted to determine whether H-NS binds cooperatively to these regions when these 
regions are juxtaposed in the context of the whole upstream intergenic region. If so, we 
predicted that lower concentrations of H-NS would be required to bind the whole region 
upstream of the icsP gene than fragments of it.  
 To test this the full length upstream intergenic region (1232 bp; icsP’) and the 
negative control fragment (1011 bp internal to the pstS gene; pstS’) were incubated with 
increasing concentrations of purified His-tagged H-NS protein and then resolved by 
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agarose gel electrophoresis.  Our results show that again H-NS binds to the upstream 
intergenic region and not to the negative control or the non-specific competitor (Fig. 
17b).  The H-NS dependent shift of the icsP’ fragment begins at 230 nM of protein with 
near complete retardation of the DNA probe by 920 nM.  Furthermore the shift observed 
with the full upstream intergenic region, occurs at approximately the same concentration 
(230 nM) as the shift observed when some of the short DNA fragments were incubated 
with H-NS (Fig. 16).  These data suggest that H-NS binds to the full length icsP upstream 
intergenic region as efficiently as it binds to some of the smaller DNA fragments used in 
our previous EMSA experiment, but not better.  This indicates that H-NS binding to the 
entire intergenic region upstream of the icsP gene does not occur cooperatively, at least 
in vitro. 
H-NS and VirB bind simultaneously to DNA located upstream of the icsP gene in 
vitro 
 Our current understanding of the mechanism of silencing/anti-silencing at the icsP 
promoter involves H-NS binding to regions of DNA with high intrinsic curvature and 
VirB antagonizing H-NS-DNA-H-NS bridges, allowing transcription to occur.  This 
understanding is based on work conducted by others, which has examined the interaction 
of H-NS with other DNA binding proteins (De la Cruz et al., 2007, Hulbert & Taylor, 
2002, Huo et al, 2009).  What remains unclear about this mechanism of transcriptional 
regulation is whether VirB causes H-NS to dissociate from the DNA, or whether VirB 
simply displaces H-NS, resulting in both proteins binding simultaneously to the DNA.  
To shed light on the mechanism of transcriptional silencing and anti-silencing at the icsP 
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promoter, we chose to study whether VirB and H-NS interacts simultaneously with the 
DNA using EMSAs.   
 The full upstream intergenic region (icsP’; 1232 bp) and our negative control (1011 
bp; pstS’) were first incubated with VirB alone (460 nM) or H-NS alone (1.8 µM). In the 
second part of the experiment, the icsP’ DNA fragment and the negative control pstS’ 
was pre-incubated with 1.8 µM of H-NS before the addition of increasing concentrations 
of VirB (120, 240 & 460 nM).  
Fig. 18.  VirB and H-NS binding of the icsP upstream intergenic region in vitro.  EMSA results 
using the full length icsP’ and pstS’ are shown.  Lanes 2 and 8 contain 460 nM purified VirB. Lanes 3 
and 9 contain 1.8 µM purified H-NS.  Lanes 4-6 and 10-12 were pre-loaded with 1.8 µM H-NS before 
increasing concentrations of VirB, 120 nM, 230 nM, and 460 nM, were added.  The lower band is 200 
nM of competitor DNA generated from pACYC184. 
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 As predicted, when VirB or H-NS were incubated independently with the DNA 
fragments (Fig. 18; lanes 2 & 8, 3 & 9), the icsP’ fragment alone was retarded in the gel 
matrix indicating the formation of specific nucleoprotein complex.  This is consistent 
with our previous observations (Fig. 17a & b).  Interestingly though, when DNA 
fragments were pre-loaded with H-NS and then incubated with 460 nM of VirB (Fig. 9, 
lanes 6 & 9), DNA-protein complexes formed on the icsP’ fragment that migrate slower  
than complexes formed by each protein individually. These data suggest that under these 
experimental conditions, VirB and H-NS simultaneously bind to the icsP’ DNA 
fragment. This could occur if VirB is displacing H-NS along the DNA or reorganizing 
the nucleoprotein complex, rather than causing the dissociation of H-NS from the DNA.  
Although it is likely that both proteins have remained associated with the DNA, future 
experiments will detect whether both protein species are present in the higher molecular 
weight complex by using mass spectroscopy, and immunodetection.  
3.4 Discussion 
 Nucleoid structuring proteins play important roles in gene silencing in many bacterial 
species (Azam & Ishihama, 1999).  Gene silencing in bacteria usually involves the 
formation of a nucleoprotein complex that renders the DNA inaccessible to DNA-binding 
proteins that are required for transcription (Azam & Ishihama, 1999, Dorman & Deighan, 
2003, Yarmolinsky, 2000).  Transcription factors that alleviate this silencing are central 
to bacterial physiology and regulate a variety of bacterial processes including virulence 
gene expression, biofilm formation, and bacterial adaptation to stress (Stoebel et al., 
2009).  The mechanisms of silencing and anti-silencing, however, are still being 
elucidated.   
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 While it has been established that H-NS is a global repressor of horizontally acquired 
genes what remains elusive is a complete picture of how H-NS represses transcription 
and how it is alleviated by other transcription factors.  In this work, we have focused on 
the regulation of the icsP gene encoded by the Shigella virulence plasmid. We describe 
regions necessary for the H-NS dependent repression of the icsP promoter and regions 
responsible for the binding of the global repressor H-NS and the major virulence factor 
VirB.  
 Our data show that H-NS represses icsP promoter activity and that VirB alleviates 
this repression (Castellanos et al., 2009).  Through deletion analysis of the icsP upstream 
intergenic region and in vivo assays, we have identified that sequences upstream of -665 
(with respect to the icsP annotated transcription start site [tss]) are needed for full 
repression of activity the promoter, although sequences between -665 and -351 appear 
sufficient for partial repression.  Although it is unusual for H-NS to impart its effects 
from so far upstream of the transcription start site, our truncation analysis of the icsP 
upstream intergenic region has shed light on how this remote regulation might occur.   
 We observed that the removal of DNA sequences upstream of -351 resulted in an H-
NS-dependent increase in promoter activity.  The simplest interpretation of these data is 
that H-NS interacts directly with sequences downstream of -351 leading to an increase in 
the activity of the promoter.  This is corroborated by our EMSA data, which shows 
specific binding of H-NS to sequences between –213 and +24 with relatively high 
affinity. Taken together, our data strongly suggests that H-NS binds to two discrete 
regions (upstream of -351 and downstream of -213) that lie upstream of the icsP gene and 
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that these two regions are separated by a region with little to no affinity for HNS (regions 
contained within T2 in Fig. 13).  
 H-NS has been demonstrated to oligomerize along DNA (Rimsky et al., 2001, Turner 
& Dorman, 2007), and form H-NS-DNA-H-NS bridges, which are described as looped 
DNA structures constrained by H-NS (Maurer et al., 2009, Stoebel et al., 2009).  Based 
on this work, it is tantalizing to imagine H-NS docked to upstream sites interacting with 
H-NS docked to downstream sites to mediate repression of the icsP promoter. Although, 
it is unusual for “classical” transcription factors to influence transcription from DNA 
binding sites located over 500 bp away, atomic force microscopy has revealed that H-NS: 
DNA: HNS bridges may involve long stretches of DNA, extending over 1 kb (Maurer et 
al., 2009), and these structures have been documented to play important roles in promoter 
silencing (Dame et al., 2000, Dame et al., 2005, Dame et al., 2006). Although we have 
no evidence to support the involvement of downstream sites in the H-NS mediated 
repression of the icsP promoter so far, this is currently being tested.  
 H-NS is well documented as displaying a binding preference for regions of DNA that 
are AT rich (Dame et al., 2005, Dame et al., 2006, De la Cruz et al., 2009, Dorman, 
2009a, Dorman, 2009c, Porter & Dorman, 1994, Rimsky et al., 2001, Shin et al., 2005, 
Stoebel et al., 2008, Turner & Dorman, 2007, Williams et al., 1996, Williams & Rimsky, 
1997, Zhang et al., 1996). These sequences typically display high levels of intrinsic 
curvature (Zuber et al., 1994).  The work presented here demonstrates that regions 
upstream of the icsP gene, which bind H-NS, coincide with regions predicted to be 
intrinsically curved, as determined by the MUTACURVE server 
(http://132.248.32.45/cgi-bin/mutacurv.cgi).  Although more recent work has revealed the 
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presence of a high affinity binding sequence for H-NS at the E. coli proU promoter 
(Bouffartigues et al. 2007, Lang et al., 2007) this 10 bp sequence was not found within 
the full-length fragment, which constitutes the intergenic region upstream of the icsP 
gene.  This suggests that H-NS recognizes sequences other than those proposed by 
Bouffartigues et al. (2007) and Lang et al., (2007).  It is possible that future 
investigations, using DNase I footprinting, may identify other sequences with high 
affinity for H-NS, which would initiate H-NS binding and oligomerization along the 
DNA.   
 Our previous studies revealed that VirB functions to derepress the icsP promoter and 
that two VirB-binding sites organized as inverted repeat and located over 1 kb upstream 
of the annotated icsP transcription start site are required for VirB-mediated derepression 
(Castellanos et al., 2009). This work is corroborated by the β-galactosidase data 
presented here.  Using EMSAs we demonstrate that VirB binds to the full upstream 
intergenic region of the icsP promoter.  This is the first indication that VirB interacts 
directly with the icsP promoter, and we hypothesize that this binding is important for de-
repression of the full-length promoter.  
 While our previous work strongly suggests that VirB interacts directly with the two 
VirB-binding sites located over 1 kb upstream of the icsP tss (Castellanos et al., 2009), 
our in vivo assays suggests that VirB may also interact with promoter proximal 
sequences.  In these experiments VirB was found to antagonize H-NS dependent 
“activation” of the icsP promoter in the shortest construct tested.  Although, this effect 
has the potential to be mediated by a VirB-regulated protein, the simplest interpretation 
of these results is that VirB interacts directly with sequence downstream of -351 to 
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mediate this effect.  Four putative VirB binding sites have been identified in this region, 
although none of these are organized as inverted repeats.  It remains unclear whether any 
of these, or other sites, mediates this VirB-dependent repression of the short fragments or, 
indeed, what they play in derepression of promoter in the context of the full upstream 
intergenic region.  Future investigations will assess the role that these downstream 
putative VirB-binding sites play in the regulation of the promoter. 
  The results obtained with the shortest construct in our truncation series are 
interesting for another reason; in the context of this construct, both H-NS and VirB 
reverse their “typical” roles, H-NS leads to an increase in promoter activity and VirB 
dampens this effect.  Although, it is well established that DNA binding proteins can serve 
dual roles, usually this phenomenon is dependent upon the location of the protein binding 
site (Corcoran & Dorman, 2009, Browning et al, 2000).  Our data suggest, at least in the 
case of the icsP upstream intergenic region, the context each protein finds itself in with 
respect to the transcription start site and to the other protein, may determine whether the 
protein serves as an activator or repressor.  These findings provide valuable insight into 
the plasticity of the molecular mechanisms that leads to transcriptional silencing and anti-
silencing in bacteria.  
 Based on our findings, we are able to propose a model of transcriptional silencing and 
anti-silencing at the icsP promoter which involves the use of remotely located binding 
sites.  At the non-permissive temperature of 30 ˚C, H-NS binds to upstream and 
downstream region in the intergenic region that lies upstream of the icsP promoter.  This 
allows the formation of an H-NS-DNA-H-NS loops or bridges between promoter distal 
(upstream of -665) and promoter proximal sequences (downstream of -213).  At the 
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permissive temperature of 37˚C, the temperature at which VirB is maximally expressed, 
VirB binds to the essential VirB-binding sites organized as an inverted repeat and located 
at position - 1144 with respect to the tss.  Although, the distance over which VirB 
mediates its effect is unusual, if this protein functions to solely antagonize H-NS-
mediated repression of the promoter, VirB may not need to bind to sites located in the 
vicinity to the icsP promoter in order to mediate transcriptional de-repression, 
eventhough putative binding sites have been found.  Regardless of which sites are 
engaged by VirB, our EMSAs suggest that the interaction of VirB with the full upstream 
intergenic region does not cause H-NS to dissociate from the DNA.  Instead, it seems 
more likely that VirB functions to reorganizes the nucleoprotein complex, which 
ultimately leads to the formation of a complex that is permissive for transcription to occur 
at the icsP promoter.  This model will be used to frame our future studies of the icsP 
promoter region and transcriptional silencing and anti-silencing mechanisms. 
 In conclusion, this study raises several questions that are central to virulence gene 
expression in Shigella and other enteric pathogens and which lie at the heart of bacterial 
physiology.  How does VirB function to alleviate H-NS dependent repression of the icsP 
promoter from such distances? Does VirB function from remote sites to regulate the 
expression of other Shigella virulence genes? Can transcription factors found in other 
bacteria function from remote sites to alleviate transcriptional repression by nucleoid 
structuring proteins? If so, how widespread is this phenomenon? We anticipate that these 
questions will be answered as transcriptional silencing and anti-silencing mechanisms in 
bacteria continue to be studied.  
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CHAPTER 4 
VIRB AND H-NS BIND TO THE ICSP PROMOTER OF SHIGELLA FLEXNERI 
AND THE ROLE OF STATIC DNA CURVATURE IN THE  
REGULATION OF ICSP  
Abstract 
 In the bacterial pathogen Shigella flexneri, many genes encoded by the large 
virulence plasmid are repressed by the nucleoid structuring protein H-NS and de-
repressed by the major virulence gene activator VirB.  One example is the icsP gene, 
which encodes an outer membrane protease.  Using electrophoretic mobility shift assays 
(EMSAs), and DNase I footprinting analysis we show that VirB binds directly to the 
upstream intergenic region of icsP and demonstrate that VirB binds to DNA sequences 
located promoter distally and proximally.  These data support a model where VirB bound 
to remote sites may act in concert with VirB bound to promoter proximal sequences to 
mediate VirB dependent de-repression of the icsP promoter. We show that the disruption 
of regions displaying high intrinsic curvature do not have an effect on either the ability of 
H-NS to repress promoter activity or VirB to alleviate this repression, at least in the 
context of the full upstream intergenic region.  Our findings enhance our understanding 
of the mechanism of transcriptional silencing and anti-silencing that control virulence 
gene expression in Shigella and raise the possibility that other bacterial promoters may be 
regulated from remote transcription factor binding sites. 
Authors: Dustin J Harrison and Helen J Wing 
We thank Dr. Eric Anderson and Dr. Martin Roop from East Carolina University for all 
their help and guidance with the EMSAs, and Stephanie Labahn for technical support. 
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4.1 Introduction 
Shigella species are gram-negative intracellular pathogens that cause bacillary 
dysentery in humans.  Shigella infections are responsible for approximately 164 million 
infections each year resulting in 1.1 million deaths, most of these occur in developing 
countries and in children less than 5 years old (Kotloff et al., 1999, Lee et al., 2005, Li et 
al., 2009).  All four Shigella species carry a large (230 kbp) virulence plasmid. Many 
genes encoded by these plasmids are under the transcriptional control of the histone-like 
nucleoid structuring protein (H-NS) and the major virulence gene activator VirB (Adler 
et al., 1989, Berlutti et al., 1998). 
H-NS is a nucleoid structuring protein that is well characterized as a silencer of 
bacterial transcription (Ali Azam et al., 1999, Dorman, 2004).  H-NS has been shown to 
oligomerize on DNA (Rimsky et al., 2001, Turner & Dorman, 2007) and this 
oligomerization can lead to the formation of H-NS-DNA-H-NS bridges, which have been 
visualized using atomic force microscopy as looped DNA structures constrained by H-NS 
(Maurer et al., 2009).  These structures may involve long stretches of DNA, extending 
over 1 kb (Dame et al., 2000, Dame et al., 2005, Dame et al., 2006, Maurer et al., 2009), 
and have been documented as playing important roles in promoter silencing 
(Bouffartigues et al., 2007, De la Cruz et al., 2009, Dorman, 2004, Dorman, 2009a, Fang 
& Rimsky, 2008, Navarre et al., 2006, Stoebel et al., 2008).  Disruption of these H-
NS:DNA complexes by other DNA-binding proteins can allow transcriptional de-
repression; a process coined anti-silencing (Fang & Rimsky, 2008, Navarre et al., 2007, 
Stoebel et al., 2008).  
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The virulence gene activator VirB is encoded by the Shigella virulence plasmid and 
its expression is regulated by another transcription factor VirF (Adler et al., 1989).  At 
the non-permissive temperature of 30 ˚C many genes encoded by the virulence plasmid 
are repressed by H-NS (Beloin & Dorman, 2003, Hromockyj et al., 1992, Porter & 
Dorman, 1994).  Upon a switch to 37 °C, a change in DNA superhelicity causes H-NS to 
dissociate from the virF promoter leading to the production of the virulence gene 
regulator, VirF (Adler et al., 1989).  VirF relieves H-NS-dependent repression of the virB 
promoter (Tobe et al., 1993, Watanabe et al., 1990) and subsequently VirB alleviates H-
NS dependent repression of many virulence plasmid genes, including icsA and those 
encoding the type III secretion system that mediate host cell invasion; ipa, mxi and spa 
(Beloin & Dorman, 2003, Berlutti et al., 1998, Dorman, 2006, Hromockyj et al., 1992, 
Maurelli et al., 1984a, Maurelli et al., 1984b, Nicoletti et al., 2008, Porter & Dorman, 
1994, Porter et al., 1998, Prosseda et al., 1998, Sasakawa et al., 1993, Tobe et al., 1991, 
Tobe et al., 1993, Tobe et al., 1995).  Transcriptional de-repression (anti-silencing) of 
virulence genes by VirF and VirB is central to the pathogenicity of Shigella. 
The mechanism underlying transcriptional silencing/anti-silencing has been proposed 
to be a straightforward molecular antagonism involving competition between the 
silencing protein and the anti-silencing protein for their overlapping cognate DNA 
binding sequences, which are usually located in the immediate vicinity of the promoter. 
Typically this competition results in the dissociation of the silencing molecule from the 
DNA (Fang & Rimsky, 2008, Navarre et al., 2007).  In contrast, at some bacterial 
promoters the anti-silencing proteins function to alter the DNA topology in a way that no 
longer allows H-NS to constrain transcription.  For example, LeuO counters silencing of 
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the quiescent porin ompS1 in Salmonella by altering the topology of the ompS1 promoter 
region (De la Cruz et al., 2007, De la Cruz et al., 2009) and in Shigella flexneri, VirB 
antagonizes H-NS by affecting the structure of the icsB promoter (Turner & Dorman, 
2007).  Previous analysis of the icsB, spa15 and virA promoters of Shigella sonnei, and 
icsB from S. flexneri, established a consensus binding site for VirB.  Our analysis of 
sequences upstream of the icsP gene identified nine sites with greater than a 6/7 match to 
the consensus, 5’-(A/G)(A/T)G(G)AAAT-3’ (Fig. 12B; Taniya et al, 2003, Turner & 
Dorman, 2007).  
Genome-wide studies have revealed that intrinsically curved DNA in the promoter 
regions of a large proportion of many important bacteria may constitute one of the most 
conserved and primitive forms of transcriptional regulation before the co-evolution of 
trans-acting factors that recognize bent DNA, e.g. DNA binding proteins (Kozobay-
Avraham et al, 2004, Prosseda et al, 2010). Static curvature of DNA has been shown to 
activate transcription, by facilitating RNA polymerase (RNAP) binding to promoters, as 
well as the nucleoid proteins IHF, and Fis which both recognize curved DNA and allow 
enhanced transcription initiation (Prosseda et al, 2004, Prosseda et al., 2010, Falconi et 
al, 1998, Falconi et al, 2001, Olivares-Zavaleta et al, 2006, Dorman & Deighan, 2003, 
Luijsterburg et al, 2006).  On the other hand, the static curvature of DNA can play an 
indirect role in the transcriptional repression allowing silencers like H-NS to engage 
DNA to stabilize or enhance a preexisting DNA loop that blocks transcription (Prosseda 
et al., 2004, Falconi et al., 1998).  Therefore, curvature is an important determinant in the 
regulation of promoter activity.  Many related bacterial species including E. coli, 
Salmonella, and Yersinia have global transcription factors, as well as specific regulators, 
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that regulate promoters with curved DNA, and we anticipate that the Shigella icsP 
promoter is no exception.  In Prosseda et al. (2004), De la Cruz et al. (2009), and Falconi 
et al. (1998) disruption of a region of curved DNA had significant effects on the ability of 
transcriptional regulators to exert their effects highlighting the importance that curved 
sequences have on transcriptional regulation. 
Our previous work shows that the icsP gene, located on the Shigella virulence 
plasmid, is repressed by H-NS and de-repressed by VirB.  We have demonstrated that the 
role of VirB is to solely alleviate transcriptional repression of the icsP promoter mediated 
by H-NS from sites over 1 kb upstream of the annotated transcription start site (Harrison 
et al., under revision, Castellanos et al., 2009, Wing et al., 2004).  Surprisingly, two 
putative VirB binding sites, organized as a perfect inverted repeat, are found in the 
extreme distal region of the icsP upstream intergenic region and are essential for the VirB 
dependent regulation of icsP in vivo (Castellanos et al., 2009).  Although our previous 
work strongly suggests VirB binds directly to this upstream intergenic region, this has 
never been categorically demonstrated.   
In this study, we examine further the role that VirB plays in the regulation of the icsP 
promoter in an attempt to discern the molecular mechanism responsible, as well as 
examining the effect that regions of intrinsic curvature have on promoter activity in the 
presence and absence of both H-NS and VirB.  Our results suggest that VirB regulates the 
activity of the icsP promoter by binding directly to the upstream intergenic region of 
icsP.  Our data also suggest that disruption of a single peak of intrinsic curvature in the 
context of the full upstream intergenic region does not have an effect on the H-NS 
mediated repression, or the VirB dependent de-repression of the promoter.  We propose a 
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model to explain how silencing and anti-silencing of the icsP promoter is achieved by 
DNA binding-proteins binding to remote sequence elements.  An improved 
understanding of the H-NS and VirB dependent regulation of the icsP promoter will 
provide insight into bacterial regulation of transcription from remote sites. 
4.2 Materials and Methods 
Bacterial strains, plasmids and media.  
 The bacterial strains and plasmids used in the present study are listed in Appendix 1. 
Bacteria were grown routinely at 37°C in Luria-Bertani (LB) broth with aeration or on 
LB agar (LB broth containing 1.5% [wt/vol] agar). Antibiotics were added at the 
following final concentrations: ampicillin, 100 µg/ml; chloramphenicol, 25 µg/ml; 
kanamycin, 50 µg/ml; and tetracycline, 12.5 µg/ml. Where appropriate, to ensure that 
Shigella strains had maintained the large virulence plasmid during manipulation, Congo 
red binding was tested on Trypticase soy broth agar plates containing 0.01% (wt/vol) 
Congo red (Sigma Chemical Co., St. Louis, Mo.). 
Construction of the PicsP-lacZ reporter plasmid and site directed mutagenesis of 
PicsP.   
 The PicsP-lacZ reporter plasmid pHJW20 was used as the basis for this work 
(Castellanos et al., 2009, Wing et al., 2004; Appendix 1).  pHJW20 carries 1232 bp 
upstream of the annotated transcription start site of the icsP promoter, the first 48 bp of 
the icsP coding region cloned upstream of a translation stop site, and a promoterless lacZ 
gene, so that expression of lacZ is directly regulated by the icsP promoter.  
 Site-directed mutagenesis was performed using the Quick Change Lightning II kit 
(Stratagene) according to manufacturer instructions.  Complimentary oligonucleotides 
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containing the mutations predicted by MUTACURVE were used to disrupt/restore the 
curvature of the icsP promoter in the template plasmid pNEO1 (Appendix 1).     
Following mutation, the 1232 bp insert was digested using PstI, PacI and cloned into 
pDH01 creating 4 plasmids designed to disrupt (D) curvature and 4 plasmids designed to 
restore (R) curvature around the predicted peaks of highest intrinsic curvature: pMut1 
D/R (-842), pMut 2 D/R (-935), pMut 3 D/R (-663), pMut 4 D/R (-435) (Appendix 1; 
Table 4 and 5).  All promoters have been sequenced.  All primers and plasmids are 
described in Appendix 1.   
Quantification of icsP promoter activity using the PicsP-lacZ reporter and 
derivatives.  
 Activity of the icsP promoter was determined by measuring β-galactosidase activity 
(Wing et al., 2004) by using the Miller protocol (Miller, 1972) in strains carrying 
pHJW20 or derivatives.  Freshly transformed cells were back-diluted 1:100 and grown 
for 4 to 5 h in either TSB medium (S. flexneri) or LB (E. coli) at 37°C prior to cell lysis 
because icsP expression significantly increases under these conditions (Wing et al., 
2004).  Assays were performed in triplicate on three separate occasions.   
In silico analyses of the icsP promoter and upstream sequences.   
 Prediction of intrinsic DNA curvature was done using MUTACURVE 
(http://132.248.32.45/cgi-bin/mutacurv.cgi).  The MUTACURVE program evaluates the 
amplitude of intrinsic curvature for every nucleotide in a given sequence using the 
algorithm of Goodsell & Dickerson (1994), with the addition of Satchwell’s contribution 
matrices for rotational and spatial displacements (Satchwell et al., 1986).  These 
algorithms have been routinely used by other investigators to identify putative H-NS 
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binding sites in DNA (Beloin & Dorman, 2003, De la Cruz et al., 2009, Flores-Valdez et 
al., 2003, Will & Frost, 2006). 
Construction of inducible plasmids and purification of the VirB and H-NS proteins.  
 The virB gene was digested from pATM324 using HindIII and NcoI restriction 
enzymes and gel purified.  The primers W38 and W39 were used to amplify the virB 
gene, which was then ligated into pQE-60 (Qiagen) before electroporation into E. coli 
M15 pREP4 creating a C-terminal His-tagged VirB in an inducible plasmid, pAJH01.  A 
similar strategy was used to create a C-terminal His-tagged H-NS in an inducible 
plasmid, pCTH01.  Briefly, the primers W134 and W137 (Appendix 1) were used to 
amplify the hns gene from Shigella flexneri serotype 2a with NcoI and BglII sites for 
cloning into pQE-60.   
 His-tagged-VirB and His-tagged-H-NS proteins were overproduced from plasmid 
pAJH01, and pCTH01 respectively.  Proteins were expressed in the E. coli strain M15 
carrying the plasmid pREP4.  The expression of C-terminally His-tagged proteins was 
induced in 500 ml cultures growing exponentially with 1mM IPTG (isopropyl-β-
thiogalactopyranoside). Two hours post-induction, the cells were harvested and frozen at 
80 °C overnight.  The cell pellet was thawed on ice and resuspended in lysis buffer (40 
mM Tris-base [pH 8.93], and 80 mM NaCl). Cells were lysed by sonication, and cellular 
debris was pelleted by centrifugation at 10 000 x g at 4 °C.  Cell lysates were applied to 
Ni-NTA columns (Qiagen) pre-equilibrated with equilibration buffer (40 mM Tris-base 
[pH 8.93], 80 mM NaCl, 10 mM imidazole).  The columns were then washed with 10 bed 
volumes of wash buffer (equilibration buffer with 20 mM imidazole) prior to elution of 
the proteins by the addition of 2.5 bed volume of elution buffer (equilibration buffer with 
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250 mM imidazole).  Eluates were analyzed by SDS-PAGE followed by Coomassie 
staining. Purified proteins were dialyzed in equilibration buffer overnight at room 
temperature. Protein concentrations were determined using Bradford Assays.  The hexa-
his tag was not found interfere with VirB expression or activity, because His-tagged VirB 
was observed to restore IcsP expression to wild type levels in a strain lacking virB in vivo 
(data not shown). Furthermore, previous studies using an identical His-tag H-NS fusion 
protein, produced in a manner similar to that described above, was shown to retain 
normal function of H-NS in assays (Williams & Rimsky, 1997).   
Electrophoretic Mobility Shift Assays (EMSAs).   
 The upstream intergenic region of the icsP promoter (1232 bp) was used as a template 
to construct six, overlapping smaller fragments, ranging from 252 bp to 358 bp by PCR 
(Appendix 1).  A positive control fragment, icsB, was made by PCR using the Shigella 
flexneri virulence plasmid as a template and the negative control, an internal fragment of 
pstS, was made using E. coli genomic DNA as the template (Appendix 1).  As a non-
specific competitor, a 147 bp fragment of DNA from pACYC184 was generated by PCR.    
The PCR probe fragments were incubated with increasing concentrations of purified 
protein, VirB (0 to 920 nM) for 30 minutes at 30°C in a 20 µl reaction mixture containing 
40 mM Tris-base (pH 8.93), 80 mM NaCl, 1 mM EDTA, 1 mM DTT, 200 ng/ml bovine 
serum albumin (BSA), 200 nM of competitor p184 DNA and 10% glycerol.  Each 
reaction mixture contained approximately 100 nM of DNA, measured using the 
NanoView (GE).  The protein-DNA complexes were resolved by electrophoresis in 1.5% 
TBE agarose gels for 4 hours at room temperature at 60 V constant.  Following 
electrophoresis the agarose gels were stained with ethidium bromide (1 µg/ml), and 
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visualized using a Typhoon 9410 (Amersham) variable mode imager.  EMSAs were 
performed a minimum of three times with representative results shown. 
DNase I footprinting.   
 Fragments of the icsP promoter were amplified by PCR (Appendix 1) before being 
restriction digested using SalI and EcoRI, and ligated into a pBluescript (Stratagene) 
vector.  The ligated plasmids were transformed by electroporation into E. coli DH10B 
cells and plated to media containing ampicillin (100 µg/ml).  Sequence analysis 
confirmed the presence of the correct icsP target sequence.  Overnight cultures of DH10B 
with the holding vector plasmids were grown overnight and back diluted 1/100 into 500 
ml cultures of LB containing ampicillin.  The cells were harvested by centrifugation and 
plasmids purified by Qiagen Mega-prep (Qiagen).  Aliquots of Mega-preps were then 
digested with SalI, or EcoR1, followed by calf intestinal alkaline phosphate (CIAP) 
digestion to remove the terminal phosphate.  Phenol:chloroform extraction removed the 
CIAP followed by ethanol precipitation.  Plasmids were next digested with SalI, or 
EcoR1, before being purified by native acrylamide gel electrophoresis.  Excised bands 
were extracted from the acrylamide and a PCR clean-up kit was used (Qiagen) before T4 
kinase end labeling with [γ32P]ATP.  End labeled products were cleaned using illustra 
ProbeQuant G-50 Micro Columns (GE Healthcare) to remove unincorporated 
radionucleotides.   
Increasing amounts of VirB or H-NS protein were incubated for 30 min at 30° C 
with a labeled probe (~200 nM of DNA) in binding buffer (40 mM Tris-base [pH 8.93], 
80 mM NaCl, 1 mM EDTA, 1 mM DTT, 200 ng/ml bovine serum albumin [BSA], 25 
µg/ml sonicated Herring sperm DNA, 200 nM of competitor p184 DNA, and 10% 
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glycerol) with protein buffer (40 mM Tris-base [pH 8.93], 80 mM NaCl, 1 mM EDTA, 1 
mM DTT, and 10% glycerol) to a final volume of 20 µl.  DNase I diluted 1:100 in 4 mM 
Tris-base (pH 8.93), 8 mM NaCl, 0.5 mM CaCl2, and 40 mM Mg Cl2, was added to the 
reaction mixtures at 30° C and incubated for 40 seconds.  The addition of stop solution 
(0.3M sodium acetate, and 5 mM EDTA) stopped the reactions.  DNA was extracted with 
200 µl of phenol:chloroform followed by ethanol precipitation.  DNA was 
electrophoresed through a 6% polyacrylamide sequencing gel run at 60 Watts constant 
until the bromophenol blue dye front migrated out of the gel.  Following completion of 
the electrophoresis the gel was dried and exposed to a phosphor-imaging screen and 
viewed on a Typhoon 9410 variable mode imager.  Protected bands were identified by 
comparison to a DNA sequencing ladder generated using the method of Maxam and 
Gilbert (Maxam & Gilbert, 1986).  Experiments were conducted a minimum of three 
times with representative images shown. 
4.3 Results and Discussion 
VirB binds the upstream intergenic region of icsP. 
 Our previous work has demonstrated the VirB dependent regulation of icsP and that 
VirB functions solely to alleviate the H-NS dependent repression of promoter activity 
(Castellanos et al., 2009, Harrison et al., under revision).  Harrison et al., (under revision; 
CH 3) showed VirB binds to the full upstream intergenic region upstream of the icsP 
gene.  However, to determine which sequences are required for VirB to bind, we again 
used electrophoretic mobility shift assays (EMSAs).  The full upstream intergenic region 
that lies upstream of the icsP gene (1232 bp) was divided up into six near equal length 
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fragments and each of these fragments were used in EMSAs with purified His-tagged 
VirB (Fig. 19).  
 For these 
experiments, a DNA 
fragment containing 
sequences that lie 
between the divergent 
icsB and ipgD genes of 
Shigella flexneri was 
used as a positive control 
(icsB), because VirB has been shown to bind to this promoter region by others (Turner & 
Dorman, 2007) and an internal fragment of the E .coli pstS gene was used as a negative 
control (pstS). Each DNA fragment (100 nM) was incubated with increasing 
concentrations of purified His-tagged VirB in the presence of a 147 bp fragment, which 
had been amplified from the plasmid pACYC184 and which served as non-specific 
competitor DNA (200 nM). DNA and DNA:protein complexes were then resolved by 
agarose gel electrophoresis. 
 Previous in vitro studies with VirB and VirB-regulated promoters have shown that the 
DNA band in EMSAs performed with VirB often do not appear as discrete shifts but are 
more diffuse which has been proposed to be evidence of protein oligomerization (Turner 
& Dorman, 2007).  Despite this, we anticipated that VirB would interact with with some 
of the DNA fragments at lower concentrations than others, in particular T6 which 
contains putative VirB binding sites that were absolutely required for the VirB dependent 
Fig. 19.  From Harrison, et al., under revision, CH 3, schematic 
showing the 6 target fragments used in the EMSAs.  Coordinates 
of each target fragment are given relative to the transcription start 
site.  Inverted triangles denote the position of a peak of high 
intrinsic curvature predicted using the MUTACURVE program. 
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de-repression of icsP promoter activity (Castellanos et al., 2009).  Included in this assay 
is T6- which is identical to T6 except that it contains the mutated VirB binding sites from 
Castellanos et al., (2009) which were shown to eliminate the VirB dependent activity of 
the promoter.  Our results show that VirB binds to target fragments T6 and T1 beginning 
at 120 nM of VirB with complete sequestration of free DNA at 230 nM.  VirB also binds 
T6-, T5, T4, and T3 but at a higher concentration of 230 nM VirB.  In contrast, T2 only 
shifts at 460 nM, the highest concentration of VirB used, but it should be noted that even 
VirB binds to the pstS negative control at this concentration.  In all but this case, VirB 
binding to the icsP promoter appears to be specific as evidenced by the uniform presence 
of free non-specific competitor DNA in all lanes and does not shift. 
Fig. 20. VirB binding within the icsP upstream intergenic region.  EMSAs were conducted using 100 
nM of each fragment shown in Fig. , as well as T6 - (mutated VirB binding site, from Castellanos et al., 
2009) and increasing concentrations of purified His-tagged VirB.  The concentrations of purified protein as 
well as the target fragment used are given above each lane.  In all cases, the lower band is 200 nM of 
competitor DNA generated from pACYC184.  Positive control, and negative controls are labeled icsB and  
pstS respectively. 0=no protein, 1 = 120 nM, 2 =230, 3=460 nM protein.  
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 The T6- fragment, which contains the mutated essential VirB binding sites identified 
in our in vivo studies (Table 1), shows a defect in the ability to bind VirB when compared 
to the wild type T6 (the shift with T6 starts at 120 nM of VirB, while T6- shows a 
moderate shift with 230 nM VirB).  These data suggest VirB may have some affinity to 
other sequences contained within this fragment, at least in vitro and under the conditions 
used.  Nevertheless, these results support our hypothesis that VirB interacts directly with 
the upstream intergenic region of icsP and supports our observation that sequences 
located over 1 kb upstream of the annotated transcription start site are required for the 
VirB dependent de-repression of the icsP promoter.  
 Target T1, which contains sequences located between 213 and +24 relative to the 
transcription start site, also shifted with low concentrations of protein.  The binding of 
VirB to this region of DNA may explain the VirB dependent decrease in icsP promoter 
activity observed at the shortest promoter construct in our in vivo assays.  The binding of 
VirB to sequences contained within this region may have disrupted an H-NS induced 
structure that increased promoter activity (Harrison et al., under revision; Fig. 14).  
Putative VirB binding sites have been found in this region, and these EMSA data, 
combined with the observations made in vivo, suggest VirB binds to these binding sites to 
antagonize H-NS in vivo, although this still needs to be tested.  Interestingly, VirB binds 
to similar fragments of the icsP upstream intergenic region as H-NS (Harrison et al., 
under revision).          
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VirB binds sequences within the intergenic region upstream of the annotated icsP 
transcription start site. 
 DNase I footprints were used to test the hypothesis that VirB binds to the upstream 
intergenic region of icsP.  The same 6 fragments of the icsP upstream intergenic region 
used in the EMSA were incubated with increasing concentrations of purified VirB (250 
nM, 500 nM, and 1 µM).  We predicted that VirB would clearly bind the DNA fragments 
identified in the EMSAs, in particular T6, and T1.  Consistent with our previous in vitro 
experiments, (Fig. 20), VirB bound to all 6 targets (Fig. 21), however, protection was 
observed with the lowest concentration of VirB (250 nM, lane 1) in targets T1, T5 and T6 
suggesting that VirB binds more efficiently to sequences contained in these fragments 
(results are summarized in Table 2). 
Target T1 shows VirB-dependent protection at a concentration of 500 nM VirB, 
before the complete protection of DNA at 1 µM.  Interestingly, no hypersensitive bands 
were observed when T1 was incubated with VirB, which would be indicative of a 
discrete DNA-protein interaction.  Instead large regions of DNase I protection are 
observed in T1, strongly suggesting VirB oligomerizes along the DNA, preventing 
DNase I access. VirB was observed to bind to sequences in T1 between +10 and -33 with 
respect to the tss.  Contained within this region are two sequences that display good 
matches to the consensus VirB binding site 5’-(A/G)(A/T)G(G)AAAT-3’ (Turner & 
Dorman, 2007, Taniya et al., 2003).  One surrounds the transcription start site (+1) and 
the other lies between -15 to -21 (although in this case the matching sequence lies in the 
opposite orientation (3’-5’) to the reported consensus).  
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Target Result 
T1 VirB bound at 500 nM; full protection at 1 µM; no hypersensitive sites 
T2 
Bands fade with 500 nM VirB, but not much more with 1 µM; no 
hypersensitive sites; VirB bound to 3 regions (-201 to -274; -296 to -337; 
and upstream of -347) 
T3 
VirB binds 2 regions; intensity of upper region remains same while lower 
region changes between 250 µM and 500 µM 
T4 Small regions of protection with VirB; no hypersensitive sites 
T5 
Protection of bands lower in the gel at 250 nM; top arrow fades out (*-829), 
while bottom arrow fades in (-896; hypersensitive) indicating a protein 
induced structural distortion 
T6 
Footprint changes at 1 µM VirB compared to 250 nM and 500 nM, with 
bands shifting up and fading out 
Table 2. Summary of VirB DNase I footprints  
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Fig. 21.  VirB binds the intergenic region of icsP.  DNase I footprints were conducted using 
approx. 200 nM of each fragment shown in Fig.19, and increasing concentrations of purified His-
tagged VirB.  The concentrations of purified protein as well as the target fragment used are given 
above each lane.  A Maxam-Gilbert G+A ladder is included as well as position of relevant bp given 
relative to the tss.  The most distal (-1130 to -1145) VirB binding sites are given labeled Box 2, Box 
1.  Red bars indicate regions of protection. * = bands protected by increasing protein concentration. 
Black arrow -896 indicates hypercleavable site. 1=250 nM VirB; 2=500 nM VirB; 3=1 µM VirB.  
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Our data strongly suggest that these sites are true VirB binding sites, although site 
directed mutagenesis of these sites will be needed to confirm this.  
 A second long region of protection can be observed extending upstream of position 
-48.  This is indicative of oligomerization.  Strikingly, the protection observed in T1 is 
more pronounced compared to the other targets, which could help explain why this target 
shifts so well with low concentrations of VirB in our EMSAs (Fig. 20). 
 In target T5, VirB bound at low concentrations (250 nM) to sequences -829 to -896, 
and to sequences upstream of -903 (sites marked with * indicate specific bases of interest 
as being protected by VirB at low concentrations).  Increasing concentrations of VirB 
resulted in a single hypercleavable site, which indicative of a protein induced structural 
distortion (-896).  This is consistent with the wrapping of the DNA around the protein, 
leading to increased sensitivity of the DNA to the DNase I enzyme.  
 In target T6, VirB bound at the low concentration of 250 nM.  Protection of 
sequences upstream of -1095 can be visualized.  Contained within T6 are the two most 
distal VirB binding sites (-1130 to -1145), which we have shown to be essential in the 
regulation of icsP (Castellanos et al., 2009).  The footprint in T6 is unusual in that, at 
high concentrations of VirB (1µM) it is possible to see protein induced distortion of the 
DNA, bands are shifted up as well as fading out.  The exact significance of this finding is 
unknown, but the unusual appearance of this footprint suggests VirB interacted with 
sequences contained within this fragment in a manner that is distinct compared to the 
other target fragments, this phenomenon was observed regularly.   
 These data suggest that VirB binds directly to the upstream intergenic region of icsP  
(both promoter distally and promoter proximally), and that VirB oligomerizes along the 
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DNA, which is consistent with previous finding regarding VirB binding (Turner & 
Dorman, 2007).  Our findings demonstrate that VirB bound to target fragments that were 
predicted to contain VirB binding sites, as well as sequences that do not contain any 
matches to the previously described VirB binding consensus sequence (e.g. T5).  This 
raises the possibility that VirB binds to sequences other than its consensus site, at least in 
vitro, and under these conditions.  Interestingly, but not surprisingly, the regions 
displaying VirB binding overlap with those shown to be protected by H-NS (Fig. 22).  
Overlapping, or similar, protein binding regions is a common feature among silencing 
and anti-silencing proteins (Navarre et al., 2006).  Taken together these data support our 
model for the regulation of icsP involving the interaction of VirB with sequences located 
both, promoter distally and promoter proximally, which likely displaces H-NS, resulting 
in a permissive structure for transcription, possibly a loop structure.  DNA looping has 
been established as a mechanism of regulation at promoters where interactions involving 
upstream and downstream regions bound by protein have been observed, and it is likely 
that icsP is no different (De la Cruz et al., 2009, Prosseda et al., 2004).  It should be 
remembered that these in vitro data, with short, linear fragments of DNA, may or may not 
adequately reflect the action of VirB in vivo.    
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H-NS binds sequences within the intergenic region upstream of the annotated icsP 
transcription start site. 
   We also predicted that H-NS would bind the regions identified in Harrison et al., 
(under revision), by EMSAs, in particular, to sites located within targets T5, T4 and T1.  
Our results demonstrate H-NS bound to all 6 targets (Fig. 22); however, protection was 
observed with the lowest concentration of H-NS (250 nM, lane 1) in targets T1, T4, T5, 
and T6 (results are summarized in Table 3).   
 T1 shows H-NS-dependent protection within 2 regions at a concentration of 250 nM 
H-NS, before the complete protection of DNA at 1 µM.  H-NS bound to sequences in T1 
between +10 upstream of the transcription start site and -33 bp downstream of the tss 
before complete oligomerization and protection of the entire region upstream of -48.  
Table 3. Summary of H-NS DNase I footprints 
Target Results 
T1 H-NS bound at low concentration (250 nM); no hypersensitive sites 
T2 H-NS binds 4 regions; Bands fade at 500 nM H-NS 
T3 Bands fade at low concentration; bands fade faster in bottom part of gel 
T4 H-NS binds 5 regions at low concentration (250 nM); 1 hypersensitive site 
upstream of -618 indicating a protein induced structural distortion 
T5 H-NS binds at low concentration (250 nM); 2 hypersensitive sites (-829 
and -896) indicating a protein induced structural distortion 
T6 Protected bands fade out at the bottom of the gel; distortion of protected 
bands similar to VirB 
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 In T4, H-NS bound to 5 regions within the fragment at low concentrations, 
corroborating our EMSA data (Fig. 16).  There is the presence of a hypercleavable site 
upstream of -618 indicating a protein induced structural distortion consistent with the 
wrapping of the DNA around the protein.  Two hypercleavable sites are also present in 
T5. 
 In target T5, H-NS bound at the low concentration of 250 nM to a region upstream of 
-903.  Surprisingly, the sites (-829 and -896; black arrows in Fig. 21) which were 
observed in T5 using VirB are again present with the H-NS protein (however with H-NS 
both are hypercleavable) indicating a protein induced structural distortion leading to 
increased sensitivity of the DNA to DNase I. 
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Fig. 22.  H-NS binds the upstream intergenic region of icsP.  DNase I footprints were conducted using 
approx. 200 nM of each fragment shown in Fig.19, and increasing concentrations of purified His-tagged H-
NS.  The concentrations of purified protein as well as the target fragment used are given above each lane.  A 
Maxam-Gilbert G+A ladder is included as well as position of relevant bp given relative to the transcription 
start site.  The most distal VirB binding sites (-1130 to -1145) are given labeled Box 2, Box 1.  Red bars 
indicate regions of protection. Black arrows indicate hypercleavable sites. 1=250 nM H-NS; 2=500 nM H-NS; 
3=1 µM H-NS. 
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 In target T6 H-NS bound to the same region as did VirB.  Again, at high protein 
concentration (1 µM) a distortion of the DNA is visible, similar to VirB.  Despite the 
striking similarities between VirB and H-NS protection signals in all the targets 
examined, there are many subtle differences in the footprints with both proteins, e.g. 
extended region of binding by H-NS in T4 compared to VirB.   
 In summary, these results demonstrate that H-NS binds directly to the upstream 
intergenic region of icsP and demonstrates the ability of H-NS to oligomerize along 
DNA, which is consistent with previous findings regarding H-NS function (Bouffartigues 
et al., 2007, De la Cruz et al., 2009, Dorman, 2004, Dorman, 2009a, Fang & Rimsky, 
2008, Navarre et al., 2006, Stoebel et al., 2008).  The hypercleavable sites in T4 and T5 
suggest that H-NS binding produces a conformational change in the DNA that is 
responsible for the H-NS induced repression.  Our data also show that H-NS binds to 
promoter proximal sequences and further supports our model for the regulation of icsP 
involving DNA looping and interaction with promoter distal and promoter proximal 
sequences being bound by H-NS (Chapter 3, Discussion).  Again H-NS bound to 
sequences that overlap regions occupied by VirB highlighting the molecular antagonism 
that exists between the two.    
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Alteration of curvature does not effect the ability of H-NS to repress promoter 
activity nor does it effect the ability of VirB to alleviate repression.   
 H-NS has been shown previously to bind to DNA with high intrinsic curvature and  
our previous findings demonstrate that both H-NS and VirB bind to similar regions 
within the icsP upstream intergenic region.  Using MUTACURVE 
(http://132.248.32.45/cgi-bin/mutacurv.cgi) to profile and predict the intrinsic curvature 
of the icsP upstream intergenic region, we have found 5 peaks displaying curvature 
values greater than 5 degrees/helical turn indicating a high degree of curvature (shown in 
Fig. 23).  The advantage of using MUTACURVE is that it allows the in silico evaluation 
of the effect that double point mutations have on the effect of curvature; to either 
disrupt/reduce or to restore curvature.  In order to examine the effect that this curvature 
Fig. 23.  In silico analysis of the static curvature of the DNA in the intergenic region of icsP. 
MUTACURVE predictions of curvature showing the 5 peaks with the highest predicted intrinsic curvature 
labeled below. >5 degrees/helical turn = curved (red line)  marks the peaks of highest intrinsic 
curvature.  Numbers below give positions of curvature relative to the tss (+1).   
     
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has on the regulation of icsP we adopted a strategy similar to that of De la cruz et al. 
(2009), making double point mutations to disrupt/reduce the curvature surrounding the 
peaks identified previously (Harrison et al., under revision; Fig. 19; Fig. 23).   
 
 The mutations that were predicted to affect DNA curvature in silico were introduced 
into the wild type icsP upstream intergenic region upstream of +1.  Each of the predicted 
peaks of curvature were disrupted separately by site directed mutagenesis before a second 
round of mutations was introduced to restore the predicted curvature without restoring the 
DNA to the original, wild type, sequence Table 2 and 3 (the predicted curvature 
surrounding the tss was not mutated).  The mutated sequences were cloned into the lacZ 
reporter plasmid used previously (Appendix 1) and transformed into either E. coli (wild 
type and a strain lacking hns) or Shigella (wild type and a strain lacking virB).  We 
expected that mutation of one of the regions of curvature would affect the ability of H-NS  
Table 4.  Substitutions to disrupt curvature 
Postition of 
curved 
region 
Predicted curvature 
value (deg/helix turn) 
prior to substitution 
Predicted curvature 
value (deg/helix turn) 
following substitution 
Base pair 
substitutions 
responsible 
-842 9.65 4.82 A>C at -876 & 
C>A at -880 
-935 9.36 5.19 G>T at -968 & 
A>C at -874 
-663 8.09 2.67 C>A at -961 & 
T>G at -696 
-435 7.88 2.99 T>G at -454 & 
A>C at -463 
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to silence, and VirB to anti-silence, promoter activity, thereby revealing the sequences 
required for the regulation of the promoter. 
 Results of the β-galactosidase assay are given in Fig. 24.  Surprisingly, comparing 
wild type (WT) to both, mutated and restored constructs, it is clear that substitutions 
predicted to disrupt curvature in each of the 4 regions had no effect on either: 1) promoter 
activity in the presence or absence of H-NS or 2) promoter activity in the presence and 
absence of VirB.  
  
 
Table 5. Substitutions to restore curvature 
Position 
of curved 
region 
Predicted 
curvature value 
(deg/helix turn) 
prior to 
substitution 
Predicted 
curvature value 
(deg/helix turn) 
following 
substitution 
Predicted 
curvature value 
(deg/helix turn) 
following 
substitution 
Base pair 
substitutions 
responsible 
-842 9.65 4.82 7.86 C>T at -876 & 
A>G at -880 
-935 9.36 5.19 7.05 T>C at -968 & 
C>T at -974 
-663 8.09 2.67 6.63 A>G at -691 & 
G>A at -696 
-435 7.88 2.99 5.18 G>A at -454 & 
C>T at -463 
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Fig. 24.  Activities of the curve disrupted icsP promoter fragments.  Activities of the curve disrupted 
promoter fragments in the presence and absence of a) H-NS or b) VirB.  Constructs are labeled 
according to the predicted position of curvature upstream of the transcription start site in order from 
highest to lowest predicted curvature.  Bars indicate β-galactosidase expression of the PicsP-lacZ 
fusions in either a) wild type E. coli MC4100 and an isogenic strain lacking hns (MC4100 hns::Knr) b) 
wild type S. flexneri 2457T and an isogenic strain lacking virB (AWY3 virB::Knr). WT icsP (pHJW20) 
is included in each lane for comparison.  β -galactosidase activities are expressed in Miller units.  This is 
a representative assay and error bars represent the mean and standard deviations. 
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 It is possible that double point mutations intended to disrupt the curvature of one 
single peak have no effect given the overall length of the upstream intergenic region 
(1232 bp), where another curved region may compensate for the reduced curvature of an 
adjoining region simply because of the plasticity of such a large A-T rich fragment of 
DNA.  It is also possible that computer software might not be able to accurately predict 
the curvature of DNA.  We are following up these experiments to test whether these 
regions are curved using biochemical tests, as described by Prosseda et al. (2004).   
 It is possible that mutations made to disrupt multiple curved regions may have a 
greater effect on H-NS and VirB function by:  i) possibly reducing the ability of the 
proteins to bind to icsP, ii) by reducing the ability of the upstream regions to interact with 
downstream regions, iii) or a combination of the two.  Future studies will address this 
concern, by disrupting multiple regions of curvature in combination, to elucidate a 
complete model of transcriptional regulation involving icsP, and these studies will frame 
the basis for future work. 
4.4 Conclusion 
 In conclusion, this study furthers our understanding of the mechanism of 
transcriptional regulation with the Shigella icsP gene, and raises several questions that 
are central to virulence gene expression in Shigella and other enteric pathogens and 
which lie at the heart of bacterial physiology.  How do VirB and H-NS interact in the full 
context of the upstream intergenic region of icsP?  In the absence of a consensus 
sequence, how is H-NS able to recognize DNA?  What effect does curvature play on the 
H-NS dependent silencing and VirB dependent anti-silencing of icsP?  These questions, 
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and many more, will need to be answered in order to achieve a complete picture of the 
mechanism of transcriptional silencing and anti-silencing.   
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CHAPTER 5 
 
CONCLUSION 
 In this work I have focused on the regulation of the icsP gene, and examined the roles 
that H-NS and VirB play in the mechanism of silencing and anti-silencing at this 
promoter.  This chapter addresses experiments that focus on five objectives.  The first 
objective was to identify regions of the icsP promoter required for H-NS mediated 
repression and VirB dependent de-repression of the promoter.  As a starting point for this 
work I conducted a promoter deletion analysis. While these experiments do not prove that 
either protein interacts directly with the icsP promoter, they allowed me to identify 
regions of the promoter needed for the VirB and, to some extent H-NS, dependent 
regulation of the icsP promoter.  These regions could then be further interrogated using 
Electrophoretic Mobility Shift Assays (EMSAs), the second objective.  The third 
objective was to determine the sequences to which H-NS and VirB bound in vitro.  The 
fourth objective was to examine the effect that icsP static DNA curvature plays in the 
ability of H-NS and VirB to regulate promoter activity.  Finally, the fifth objective was to 
propose a mechanism for the H-NS and VirB regulation of the icsP promoter.   
 In Chapter 2, my data show that H-NS represses icsP promoter activity and that VirB 
alleviates this repression from sites located over 1 kb upstream of the annotated 
transcription start site (Castellanos et al., 2009).  Through deletion analysis we have also 
identified a region located promoter distally, -1130 to -1144, that is required for the de-
repression of promoter activity.  Located in this distal region are two VirB binding sites, 
organized as an inverted repeat, 5’-CGGGGATTTCAGTATGAAATGAAGTA-3’(wild type 
VirB boxes shown here; Table 1), that were identified in an in silico analysis, and shown 
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to be absolutely required for the VirB dependent de-repression of the promoter.  Our data 
revealed that complete mutagenesis of the upstream binding site (box 2), the downstream 
binding site (box 1) or both, resulted in complete loss of VirB dependent regulation of the 
icsP promoter (Table 1).  To our knowledge, this is the first evidence that VirB can 
influence promoter activity from such distal sites.  Although it is unusual for H-NS and 
VirB to impart its effects from so far upstream of the transcription start site, our 
truncation analysis of the icsP upstream intergenic region has shed light on how this 
remote regulation might occur, but raises some very important questions: (i) Are other 
Shigella virulence plasmid genes regulated from remote VirB binding sites?  (ii) Is it 
common for transcriptional silencing and anti-silencing mechanisms to employ distal 
regulator binding sites? 
 The experiments described in Chapter 3, focus on the regulation of the icsP promoter 
by H-NS.  Through deletion analysis of the icsP upstream intergenic region and in vivo 
assays, I, and others in the Wing lab, identified that sequences upstream of -665 (with 
respect to the icsP annotated transcription start site [tss]) are needed for full H-NS 
induced repression of activity the promoter, although sequences between -665 and -351 
appear sufficient for partial repression.  Furthermore, our data strongly suggests that H-
NS binds to two discrete regions (upstream of -351 and downstream of -213) in vivo, that 
lie upstream of the icsP gene. This observation is backed up by in vitro EMSAs and 
based on our assays it seems that these two regions are separated by a region with little to 
no affinity for HNS (regions contained within T2 in Fig. 16).  Both regions to which H-
NS binds, contain sequences predicted to display high levels of intrinsic curvature. These 
data support a model where H-NS docked at remote sites may act in concert with H-NS 
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docked at promoter proximal sequences to mediate H-NS-dependent repression of the 
icsP promoter. While we again demonstrate that VirB functions solely to de-repress the 
promoter, our EMSA data indicate that VirB and H-NS are capable of binding 
simultaneously to the full intergenic region (1232 bp) that lies immediately upstream of 
the icsP gene.  This suggests that VirB may function to relocate H-NS, rather than 
causing H-NS to dissociate from the DNA upstream of the icsP gene.   
 In Chapter 4, my work has demonstrated that VirB binds the upstream intergenic 
region of icsP, and I have shown that both VirB and H-NS oligomerize along the DNA.  I 
have also investigated the role that DNA intrinsic curvature plays in the regulation of 
icsP.  Using electrophoretic mobility shift assays (EMSAs), and DNase I footprinting 
analysis I show that VirB binds directly to the upstream intergenic region of icsP and 
demonstrate that VirB and H-NS bind and oligomerize to DNA sequences located 
promoter distally and proximally.  From these results we conclude that both H-NS and 
VirB interact directly with the icsP promoter and confirm our in vivo results 
demonstrating that sequences located over 1 kb upstream of the annotated tss are required 
for the H-NS dependent silencing and the VirB dependent anti-silencing of the icsP 
promoter.  These data support a model where VirB bound to remote sites may act in 
concert with VirB bound to promoter proximal sequences to mediate VirB dependent 
anti-silencing of the icsP promoter.  
 In Chapter 4, I also show that the disruption of single regions displaying high intrinsic 
curvature do not have an effect on icsP promoter activity.  These regions of predicted 
curvature were mutated using site directed mutagenesis to disrupt and ultimately restore 
the curvature.  Surprisingly, disruption of these regions of predicted curvature did not 
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have an effect on either the ability of H-NS to silence the promoter or the ability of VirB 
to alleviate the H-NS induced repression.  Likewise, mutations to restore the predicted 
curvature had no effect.  It is likely that disruption of a single peak within the context of 
1.2 kb is not sufficient to elicit an effect. 
 Taken together, these data have allowed us to propose a model for the regulation of 
icsP.  At the non-permissive temperature of 30 ˚C H-NS binds and induces H-NS-DNA-
H-NS loops or bridges between promoter distal and promoter proximal sequences.  At the 
permissive temperature of 37 ˚C, the temperature at which VirB is maximally expressed, 
VirB binds to its consensus site (Taniya et al., 2003, Tobe et al., 1991, Turner & 
Dorman, 2007), which is AT rich and frequently lies in AT rich stretches of DNA.  These 
sequences likely are already bound by H-NS.  We hypothesize that VirB does not 
completely remove H-NS from the DNA, but instead binds simultaneously and possibly 
re-organizes the DNA:protein complex by binding to promoter distal VirB binding sites 
in conjunction with promoter proximal sequences bound by VirB.  The nucleoprotein 
complex might be stabilized through the interaction of VirB bound to sites located 
internally.  This multi-region DNA:protein interaction then possibly leads to a re-
organization of the topology of the upstream intergenic region that is permissive for icsP 
promoter activity (Fig. 25).  This model should frame our future investigations. 
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 While the work containd herein contributes to our knowledge, much more work is 
required to build a complete picture of transcriptional silencing and anti-silencing at the 
icsP promoter.  It would be interesting to asses the contribution of all the VirB binding 
sites identified in Castellanos et al. (2009) in the regulation of the icsP promoter, and to 
examine whether a VirB:DNA:VirB loop is responsible for the observed effects 
presented in this work.  Site directed mutagenesis of combinations of putative VirB 
binding sites would indicate which sequences are essential, and could be combined with 
Fig. 25. Proposed model for the regulation of icsP by H-NS and VirB. The upstream intergenic region of 
icsP (a) showing the two distal, essential, VirB binding sites (black arrows under the red box).  At the non-
permissive temp of 30 °C H-NS induces repression of promoter activity by binding to sequences located 
distally and proximally, resulting in a plectonemic structure stabilized by oligomerization of H-NS (b).  
Upon a shift in temperature, to the permissive temperature of 37 °C, VirB is expressed and binds to icsP.  
Instead of displacing H-NS, VirB binds simultaneously causing the reorganization in the topology of the 
promoter, interacting with the 2 most distal VirB binding sites and promoter proximal sites.  The resulting 
structure is stabilized through VirB bound to internal sequences.  The altered architecture of the promoter is 
permissive for transcription (c). Shown is a VirB monomer; H-NS in dimeric form; bent arrow = tss.     
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KMNO3 footprinting to demonstrate a loop(s) is/are being formed.  The intergenic region 
that lies upstream of icsP is very AT rich, and typically such sequences have high 
intrinsic curvature.  While our initial results suggest that no single region of predicted 
curvature is required it could be that disruption of multiple peaks in combination will 
produce an observable effect.  Therefore, it would also be interesting to assess the effect 
of combinations of disrupted peaks on the ability of H-NS and VirB to regulate promoter 
activity.  
 It would be beneficial to investigate the possibility that a multi-protein complex is 
involved in icsP regulation, similar to situations described in other promoters (Browning 
et al., 2000).  The VirB protein is homologous to the P1 protein ParB, and the ParB 
binding site, parS, shows a high degree of similarity to the icsB binding site described by 
Turner & Dorman (2007) and Taniya et al. (2003) (Beloin et al., 2002, Taniya et al., 
2003, Surtees & Funnell, 2001).  We have shown that the essential distal VirB binding 
site in icsP shows sequence homology with both these sites (parS and icsB).  An in silico 
analysis of this region using the Softberry software BPROM, which analyzes bacterial 
promoters, predicts an integration host factor (IHF) binding site oriented in a similar 
position to that found in parS.  In the parS system, IHF bends the parS site which allows 
ParB to contact its specific binding motifs located on either side of the bend resulting in a 
high affinity protein:DNA complex.  Therefore, I have made an IHF mutant in Shigella 
and preliminary data suggests the possible involvement of IHF in the regulation of 
promoter activity and should be followed up (See Appendix 2 for full description).  To 
find other potential candidates, chemical cross-linking of proteins, followed by co-
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immunoprecipitation should be able to pull out any proteins associating with VirB, and 
likewise icsP.   
 Finally, a closer examination of the sequences to which VirB is able to bind might 
elucidate a more complete description of a VirB binding site.  Evidence for this comes 
from the observation that VirB bound very well to T5 by DNase I footprint analysis, and 
is worthy of further study.   
 In conclusion, this work has focused on the regulation of icsP and has examined the 
roles that H-NS and VirB play in the mechanism of silencing and anti-silencing.  This 
work has shed light on the phenomenon of regulation from remote sites, yet it raises 
many more questions.  Does VirB function from remote sites to regulate the expression 
of other Shigella virulence genes? An in silico analysis of another H-NS and VirB-
regulated promoter located on the Shigella virulence plasmid, icsB-ipgD (Turner & 
Dorman, 2007), reveals the presence of additional putative VirB binding sites with the 
most distal located at -1615, and -1464 upstream of the ipgD tss, and one located at -1625 
Fig. 26.  In silico analysis of the icsB-ipgD promoter region.  In silico analysis reveals the presence 
of additional putative VirB binding sites that show consensus sequence matches to the reported VirB 
binding site.  The binding sites in icsB are located at: -1625, -390, and -361 upstream of the tss.  The 
binding sites in ipgD are located at: -1615, -1464, and -289 upstream of the tss.  Arrows show direction 
of the binding site 5’ - 3.’  Binding site sequence is given below the figure.  Figure is drawn to scale.   
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upstream of the icsB tss, respectively (Fig. 26).  Is it possible that these divergently 
transcribed genes are regulated from remote sites? 
 Can transcription factors found in other bacteria function from remote sites to 
alleviate transcriptional repression by nucleoid structuring proteins? If so, how 
widespread is this phenomenon?  Silencing and anti-silencing mechanisms that control 
expression of virulence genes in Shigella and many other bacteria, is central to 
understanding pathogenesis.  However, these mechanisms are not restricted to the human 
pathogens but may be more wide spread, we need only look.     
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APPENDIX 1 
BACTERIAL STRAINS, PLASMIDS, AND PRIMERS 
 
 
Table 1 Bacterial strains and plasmids 
Strain or 
Plasmid 
Descriptiona Source or 
Reference 
Strains   
E. coli   
MC4100  E. coli strain K-12 with araD and lacZ deletion (Pogliano & 
Beckwith, 1994) 
MC4100 hns MC4100 hns::Knr (Yamada et al., 1991) 
S. flexneri   
2457T S. flexneri  serotype 2a (Formal et al., 1958) 
   AWY3 2457T virB::Tn5; Knr (Wing et al., 2004) 
   
Plasmids   
pACYC184 Cloning vector; p15A replicon Tetr/Cmr/source of 
non-specific competitor DNA 
(Rose, 1988) 
pHJW7 icsP promoter region transcriptionally fused to lacZ 
in pACYC184 Cmr.  
(Wing et al., 2004) 
pBluescript Cloning vector Stratagene 
pQE-60 Cloning vector for production of C-terminally His-
tagged proteins 
Qiagen 
pHJW20 pHJW7 lacking XbaI site downstream of lacZ gene. 
Carries 1232 bp of native sequence upstream of the 
icsP transcription start site  
(Wing et al., 2004) 
pJS01 pHJW20 carrying 1056 bp of native sequence 
upstream of the icsP transcription start site.  
(Castellanos et al., 
2009) 
pJS02 pHJW20 carrying 891 bp of native sequence 
upstream of the icsP transcription start site. 
(Castellanos et al., 
2009) 
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pDH01 pHJW20 carrying 663 bp of native sequence 
upstream of the icsP transcription start site. 
(Castellanos et al., 
2009) 
pJS04 pHJW20 carrying 351 bp of native sequence 
upstream of the icsP transcription start site. 
(Castellanos et al., 
2009) 
pHJW34 pHJW20 carrying 254 bp of native sequence upstream of 
the icsP transcription start site. 
(Castellanos et al., 
2009) 
pHJW35 pHJW20 carrying 150bp of native sequence upstream of 
the icsP transcription start site. 
(Castellanos et al., 
2009) 
pHJW36 pHJW20 carrying 92 bp of native sequence upstream of 
the icsP transcription start site. 
(Castellanos et al., 
2009) 
pMIC01 pHJW20 with 33bp deleted between SalI and PstI sites in 
the multiple cloning site of pACYC184 this changes the 
context of the upstream icsP promoter sequences.  
(Castellanos et al., 
2009) 
pMIC02 pHJW20 carrying 1437 bp of native sequence upstream 
of the icsP transcription start site. 
(Castellanos et al., 
2009) 
pMIC13 pHJW20 with all 7 bps substituted in promoter proximal 
upstream VirB binding site  
(Castellanos et al., 
2009) 
pMIC17 pHJW20 with all 7 bps substituted in distal upstream 
VirB binding site 
(Castellanos et al., 
2009) 
pMIC18 pHJW20 with all 7bps substituted in both upstream VirB 
binding sites 
(Castellanos et al., 
2009) 
pShfT1 EMSA/DNase I footprint Target#1 in pBluescript This work 
pShfT2 EMSA/DNase I footprint Target#2 in pBluescript This work 
pShfT3 EMSA/DNase I footprint Target#3 in pBluescript This work 
pShfT4 EMSA/DNase I footprint Target#4 in pBluescript This work 
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pShfT5 EMSA/DNase I footprint Target#5 in pBluescript This work 
pShfT6 EMSA/DNase I footprint Target#6 in pBluescript This work 
pAJH01 IPTG inducible vector carrying his-virB This work 
pCTH01 IPTG inducible vector carrying his-hns  This work 
pBAD18 L-arabinose inducible pBAD expression vector, pBR 
ori; Ampr  
(Guzman et al., 
1995) 
pATM324 pBAD18-virB; Ampr ((Schuch et al, 1999) 
pNEO1 PstI, XbaI insert of icsP cloned into pBluescript.  
Carries 1232 bp of native sequence upstream of the 
icsP transcription start site. Used as template for site-
directed mutagenesis 
This work 
pMut1 D pHJW20 with 2bp substitution to disrupt curvature at -
842 
A>C at -876 & C>A at -880 relative to icsP tss. 
This work 
pMut2 D pHJW20 with 2bp substitution to disrupt curvature at -
935 
G>T at -968 & A>C at -974 relative to icsP tss. 
This work 
pMut3 D pHJW20 with 2bp substitution to disrupt curvature at -
663 
C>A at -691 & T>G at -696 relative to icsP tss. 
This work 
pMut4 D pHJW20 with 2bp substitution to disrupt curvature at -
435 
T>G at -454 & A>C at -463 relative to icsP tss. 
This work 
pMut1 R pHJW20 with 2bp substitution to restore curvature at -
842 
C>T at -876 & A>G at -880 relative to icsP tss. 
This work 
pMut2 R pHJW20 with 2bp substitution to restore curvature at -
935 
T>C at -968 & C>T at -974 relative to icsP tss. 
This work 
pMut3 R pHJW20 with 2bp substitution to restore curvature at -
663 
A>G at -691 & G>A at -696 relative to icsP tss. 
This work 
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pMut4 R pHJW20 with 2bp substitution to restore curvature at -
435 
G>A at -454 & C>T at -463 relative to icsP tss. 
This work 
a Ampr, ampicillin resistance; Tetr, tetracycline resistance; Cmr, chloramphenicol 
resistance; Knr, kanamycin resistance 
 
 
Table 2 Oligonucleotide Primers 
Primer Sequencea 5'-3' Description or 
useb 
W1016 CAGATAAAATATTTCAAGATTTCAGTGC 
Mutation of XbaI 
binding site 
downstream of the 
lacZ gene. 
W1017 CCCGCATCCACAGGACGGGTGTGGTCG 
Used with W1016 
to create ‘mega’-
primer lacking 
XbaI site. 
W1018 GTGAGAGGGCCGCGGCAAAGCC 
Used with 
‘mega’-primer to 
create fragment 
lacking  XbaI site. 
W530 GGGTACCTGCAGTAAAAGATATGTTCTTGG 
Binds to 
sequences -92 to -
75 relative to the 
icsP tss. Used 
with W48 to make 
pHJW36.  
W44 GGGTACCTGCAGGCCTCTTTATTATAAGTAAGATCTGGC 
Binds to 
sequences -1056 
to -1030 relative 
to the icsP tss. 
Used with W48 to 
make pJS01. 
W45 GGGTACCTGCAGAGTGAACTCTCGCCCTATACGGCG 
Binds to 
sequences -891 to 
-868 relative to 
the icsP tss. Used 
with W48 to make 
pJS02. 
W46 GGGTACCTGCAGTTTGGTCACTTTAACTGTATTAGTCGC 
Binds to 
sequences -663 to 
-637 relative to 
the icsP tss. Used 
with W48 to make 
pDH01. 
W47 GGGTACCTGCAGGTTGGTACTGAAAGGCACGTTGGC 
Binds to 
sequences -351 to 
-328 relative to 
the icsP tss. Used 
with W48 to make 
pJS04. 
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W528  GGGTACCTGCAGGGCGAGAGAACAAGAAGGTGAGTAG 
Binds to sequences -
254 to -241 relative to 
the icsP tss. Used with 
W48 to make 
pHJW34.  
W529  
 GGGTACCTGCAGCTTTATTCGCACAATGAGG 
Binds to sequences -
150 to -132 relative to 
the icsP tss. Used with 
W48 to make 
pHJW35.  
W530 
 GGGTACCTGCAGTAAAAGATATGTTCTTGG 
Binds to sequences -92 
to -75 relative to the 
icsP tss. Used with 
W48 to make 
pHJW36.  
W63 TGAGACGTCGACAGAACTCTACTTTTTTGGTTGAAATGTCC 
Binds to sequences -3 
to +24. Used to make 
icsP promoter 
Target#1 Reverse 
W144 CCGGGAATTCTTGTCGCGGAATCCTGAAACTATCAGCC 
Binds to sequences -
227 to -200. Used to 
make icsP promoter 
Target#1 Forward 
W65 TGAGACGTCGACTCATTGTGCGAATAAAGTAACGGGGGC 
Binds to sequences -
160 to -134. Used to 
make icsP promoter 
Target#2 Reverse 
W145 CCGGGAATTCAGGTTGTCATGTTGTGACTGAAAGGC 
Binds to sequences -
361 to -336 . Used to 
make icsP promoter 
Target#2 Forward 
W67 TGAGACGTCGACCGATAAGACAATAAATTGTCATCACGGC 
Binds to sequences -
320 to -293. Used to 
make icsP promoter 
Target#3 Reverse 
W157 CCGGGGATCCTCTGACTCTCGACTTTAAAAGGATGGG 
Binds to sequences -
635 to -608 . Used to 
make icsP promoter 
Target#3 Forward 
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W69 TGAGACGTCGACGGGCACCTCACTTTAGCACTGAAGCC 
Binds to sequences -
548 to -523 . Used to 
make icsP promoter 
Target#4 Reverse 
W147 CCGGGAATTCGCGTTTTCAAGGATTAGTCCTTAATCGG 
Binds to sequences -
870 to -843 . Used to 
make icsP promoter 
Target#4 Forward 
W71 TGAGACGTCGACAATAAATATTCTACTAATTTAATGCATCAC 
Binds to sequences -
759 to -730 . Used to 
make icsP promoter 
Target#5 Reverse 
W148 CCGGGAATTCAAGCCTCTTTATTATAAGTAAGATCTGGC 
Binds to sequences -
1058 to -1030 . Used 
to make icsP 
promoter Target#5 
Forward 
W73 TGAGACGTCGACCAATAAAATGGTTGGTTGAAGGTCGTG 
Binds to sequences -
995 to -969. Used to 
make icsP promoter 
Target#6 Reverse 
W149 CCGGGAATTCATGCTTGATAACTTAATTGGGGCTCCC 
Binds to sequences -
1214 to -1188. Used 
to make icsP 
promoter Target#6 
Forward 
W81 ATGTTTATGATACCTGCAGG 
Binds to sequences -
1219 to -1232 relative 
to the icsP tss. Used to 
amplify sequences 
contained in pMIC02. 
W82 AGGACTTCCGTCGACCAGGAAATAGTGCGGGCAAC 
Binds to sequences -
1473 to -1454 relative 
to the icsP tss. Used to 
amplify sequences 
contained in pMIC02. 
W89 CAAATTATCTAGAAAAGATCGCAGG 
Binds downstream of 
the transcription start 
site in icsP gene. Used 
in the construction of 
pMIC13, 17 & 18. 
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W98 CCCGTTCCATGTGCTCGCC 
Binds to pACYC184 
upstream of cloned 
sequences. Used in the 
construction of 
pMIC13, 17 & 18. 
W99 /5Phos/ACTGAAATCCCCGGAAGTATTCAATC 
Binds to promoter 
proximal upstream 
VirB binding site; wild 
type sequence. Used in 
the construction of 
pMIC17. 
W100 /5Phos/AGCTGGGCCCCCGGAAGTATTCAATC 
Binds close to 
promoter proximal 
upstream VirB binding 
site used to mutate this 
sequence. Used in the 
construction of 
pMIC13 & 18. 
W101 /5Phos/ATGAAATGAAGTATATTTAATATACTTTAC 
Binds to distal 
upstream VirB binding 
site; wild type 
sequence. Used in the 
construction of 
pMIC13. 
W110 /5Phos/CGACCCGGAAGTATATTTAATATACTTTAC 
Binds close to distal 
upstream VirB binding 
site used to mutate this 
sequence. Used in the 
construction of 
pMIC17 & 18. 
W149 CCGGGAATTCATGCTTGATAACTTAATTGGGGCTCCC 
Binds to 
sequences -1214 
to -1188. Used to 
make icsP 
promoter 
Target#6 Forward 
W75 CCGGGAATTCTCAATGAAATTGCTAATT 
icsB positive control 
Reverse (Turner & 
Dorman, 2007)  
W76 CCGGGAATTCATGCAATCCCAAATTAGT 
icsB positive control 
Forward (Turner & 
Dorman, 2007) 
W77 TGAGACGTCGACCCACTCTTCGTTCACTTTCGCC 
pstS negative 
control Forward 
binds internal to 
translation start 
site 
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W78 GTGTCAGTCGACCTCAGGAAGGTCTGTTCCAGTTCCC 
pstS negative 
control Reverse 
binds internal to 
translation start 
site 
W108 GTGTCAGTCGACTATTGGTCTTCCACGCAGCGC 
pstS' negative 
control Reverse 
orf 
W109 GTGTCAGTCGACTTATGAAAGTTATGCGTACCACCG 
pstS' negative 
control Forward 
orf 
W38 CAGGGTGTGCCATGGTGGATTTGTGC Used to clone virB into pQE60  
W39 
CAGCTAATTAAGCTTAGTGATGGTGATGGTGATGTCCTGAAGAC
GATAGATGGC 
Used to clone 
virB into pQE60 
W134 TCATTCCCATGGCCGAAGCACTTAAAATTCTGAAC Used to clone hns into pQE60   
W135 TCATTCAGATCTTTGCTTGATCAGGAAATCGTCG Used to clone hns into pQE60 
W112 CGCATTGTTAGATTTCATACACGG 
Reverse primer 
binds downstream 
of ClaI in 
pACYC184 used 
to make non-
specific 
competitor DNA. 
W113.1 AAATGTAGCACCTGAAGTCAGCC 
Forward primer 
binds upstream of 
ClaI in 
pACYC184 used 
to make non-
specific 
competitor DNA. 
W206 TCCTTGAAAACGCCGTATCGGGAGAGAGTTCACTCTATTG 
Forward primer 
to disrupt 
curvature at -
842 relative to the 
icsP tss  
W207 CAATAGAGTGAACTCTCTCCCGATACGGCGTTTTCAAGGA 
Reverse primer 
to disrupt 
curvature at -
842 relative to the 
icsP tss 
W208 CCACTACTGAACTATTCTGGGATTTAAATTCAATACAATGGTTGGTTGAAGGTC 
Forward primer 
to disrupt 
curvature at -
935 relative to the 
icsP tss 
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W209 GACCTTCAACCAACCATTGTATTGAATTTAAATCCCAGAATAGTTCAGTAGTGG 
Reverse primer 
to disrupt 
curvature at -
935 relative to the 
icsP tss 
W210 GTTATCCTCTACACATTTTATCTAATGTGTACTTGGACAATTCATTGGTGC 
Forward primer 
to disrupt 
curvature at -
663 relative to the 
icsP tss 
W211 GCACCAATGAATTGTCCAAGTACACATTAGATAAAATGTGTAGAGGATAAC 
Reverse primer 
to disrupt 
curvature at -
663 relative to the 
icsP tss 
W212 GTATAGTTTTTCAGATTTTGTTTGTCCCGTGACATATTATGGAAATGGCAGAAGCA 
Forward primer 
to disrupt 
curvature at -
435 relative to the 
icsP tss 
W213 TGCTTCTGCCATTTCCATAATATGTCACGGGACAAACAAAATCTGAAAAACTATAC 
Reverse primer 
to disrupt 
curvature at -
435 relative to the 
icsP tss 
W214 TCCTTGAAAACGCCGTATTGGGGGAGAGTTCACTCTATTG 
Forward primer 
to restore 
curvature at -
842 relative to the 
icsP tss 
W215 CAATAGAGTGAACTCTCCCCCAATACGGCGTTTTCAAGGA 
Reverse primer 
to restore 
curvature at -
842 relative to the 
icsP tss 
W216 ACTACTGAACTATTCTGGGATTTAAATCCAATATAATGGTTGGTTGAAGGT 
Forward primer 
to restore 
curvature at -
935 relative to the 
icsP tss 
W217 ACCTTCAACCAACCATTATATTGGATTTAAATCCCAGAATAGTTCAGTAGT 
Reverse primer 
to restore 
curvature at -
935 relative to the 
icsP tss 
W218 GTTATCCTCTACACATTTTATCTGATGTATACTTGGACAATTCATTGGTGC 
Forward primer 
to restore 
curvature at -
663 relative to the 
icsP tss 
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W219 GCACCAATGAATTGTCCAAGTATACATCAGATAAAATGTGTAGAGGATAAC 
Reverse primer 
to restore 
curvature at -
663 relative to the 
icsP tss 
W220 GTATAGTTTTTCAGATTTTGTTTATCCCGTGATATATTATGGAAATGGCAGAAGCA 
Forward primer 
to restore 
curvature at -
435 relative to the 
icsP tss 
W221 TGCTTCTGCCATTTCCATAATATATCACGGGATAAACAAAATCTGAAAAACTATAC 
Reverse primer 
to restore 
curvature at -
435 relative to the 
icsP tss 
 
a Restriction sites underlined.  
b tss, transcription start site. 
c Bold indicates bases mutated by site directed mutagenesis 
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APPENDIX 2 
 
PRELIMINARY EXAMINATION OF THE INVOLVEMENT OF IHF IN THE 
REGULATION OF THE ICSP PROMOTER 
 
 
 The VirB protein is homologous to the P1 protein ParB, and the ParB binding site, 
parS, shows a high degree of similarity to the icsB binding site described by Turner & 
Dorman (2007) and Taniya et al. (2003) (Beloin et al., 2002, Taniya et al., 2003, Surtees 
& Funnell, 2001).  We have shown that the essential distal VirB binding site in icsP 
shows sequence homology with both these sites (parS and icsB).  An in silico analysis of 
this region using the Softberry software BROM, which analyzes bacterial promoters, 
predicts an integration host factor (IHF) binding site oriented in a similar position to that 
found in parS (Fig. 27).   
 
 Based on this finding, I conducted a preliminary experiment to assess the potential 
contribution that IHF makes in the regulation of icsP promoter.  IHF exists as a 
Fig. 27.  Comparison of P1 parS and icsP.  Comparison of the P1 parS and icsP sites showing the ParB 
binding sites in parS (upper) and the VirB binding sites in icsP (lower).  The IHF binding site is shown for 
parS and the BPROM predicted IHF site is shown in icsP.  parS (Surtees & Funnell, 2001). 
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heterodimeric sequence specific DNA binding protein and functions as both a structural 
element in the cell and as a conventional regulator of gene expression.  The two subunits 
of the protein are encoded by the chromosomal genes himA and himB (also seen in the 
literature as ihfA and ihfB) (Funnell, 1988).  Its role is to bend DNA up to 180° which 
facilitates the formation of nucleoprotein complexes.  IHF is a positive regulator of both 
virF and virB (Porter & Dorman, 1997).   
 Through P1 transduction I introduced a tetracycline resistance cassette into the himA 
gene of Shigella flexneri 2a, wild type and an isogenic strain lacking virB, to ablate the 
function of the IHF protein.  Similar strategies have been used to disrupt IHF function 
since IHF exists as a heterodimeric protein; disruption of either gene is sufficient to 
destroy function (Funnell, 1988).  These cells were transformed with our reporter plasmid 
containing the full upstream intergenic region of icsP::lacZ and assayed in the β-
galactosidase assay (described in materials and methods, chapters 2, 3 and 4).  The results 
in Fig. 28 suggest that IHF does not play a role in the VirB dependent regulation of icsP 
promoter activity.   
 In the parS system, IHF bends the parS site which allows ParB to contact its specific 
binding motifs located on either side of the bend resulting in a high affinity protein:DNA 
complex.  However, in the absence of IHF, ParB binds specifically, but more weakly to 
parS and only requires the right half of the parS site for activity (Vecchiarelli et al, 
2007).  Therefore, it could be possible that in our reporter system the absence of IHF is 
not sufficient to produce a defect in the ability of VirB to regulate promoter activity, in 
fact, the data suggests that in the absence of himA- the presence of VirB increases 
promoter activity above what is seen in the wild type.  Could this be evidence for IHF 
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participation in promoter regulation?  It is an interesting finding that bears further 
investigation. It would be interesting to investigate the interaction between VirB, H-NS, 
and IHF.  An E. coli MC4100 himA- construct has been made, however, the hns-, himA- 
double knock out has been difficult to create as this is likely deleterious to the cell, but 
the potential information that could be gained from demonstrating a mulit-nucleoprotein 
complex in the regulation of icsP would be worth the effort. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. IHF does not regulate icsP promoter activity.  β-galactosidase assay of the full upstream 
intergenic region of icsP::lacZ (pHJW20).  Bars indicate β-galactosidase expression in the presence and 
absence of virB, himA and the double mutant lacking both.  β-galactosidase activities are expressed in 
Miller units and mean and standard deviations are shown.  This graph is a representative sample. 
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